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Central nervous system (CNS) function depends on both the connections 
between the underlying neurons and neural circuits and their activity. Neuronal activity 
in turn can be classified as neurotransmission and neuromodulation, where 
neuromodulation serves as a means to adapt neurotransmission to the different 
behavioral needs of the animal. Here, using the well-described monosynaptic stretch 
reflex (MSR) spinal circuit as a tool, we compared in the in vitro mouse spinal cord 
preparation the modulatory actions of DA in spinal lumbar segments that mediate 
somatosensory input and locomotor output with segments that additionally house the 
final common output of the autonomic nervous system (ANS). As the ANS contributes to 
the activation of the cardiac system and as a dysfunction of the DA system and the DA 
D3 receptor is associated with an increased prevalence of hypertension, we next 
addressed the potential role of DA modulation on the ANS in vivo, and in particular its 
role in hypertension and with age.  
In the first part of this thesis, we provide evidence that DA exerts opposing 
modulatory effects in ANS-containing segments when compared to segments void of 
ANS innervation and that this switch in DA modulation in the thoracic spinal cord is 
reversed by gap junction blockers. 
	  In the second part of the study, we show that aging-related increases in blood 
pressure and cardiac function in control wild-type (WT) animals were accompanied by 
bradycardia in the oldest animals. Interestingly, young D3 receptor knockout (D3KO) 
mice displayed blood pressure and heart rate values that were significantly increased 
over their age-matched WT controls but similar to those of the old WT group.  
Ultrasound echocardiography revealed aging-related increases in heart ventricle size in 
WT animals, but no similar changes in D3KO. In contrast, functional analyses revealed 
that ejection fraction and fractional shortening were compromised in old WT animals 
and similar to young D3KO mice. Subsequent histological assays demonstrated an 
aging-related interstitial fibrosis that peaked in old WT and that was similar to old WT in 
young D3KO mice. 
Taken together, our data suggest that DA–mediated neuromodulatory actions of 
spinal cord circuits are dependent on the underlying spinal circuitry, and they suggest 
that a dysfunction of the D3 receptor pathway is sufficient to mimic the increased 
hypertension and cardiac remodeling observed in the aging heart. 
  
	    
	  DOPAMINERGIC MODULATION OF THE AUTONOMIC NERVOUS SYSTEM:   
IN VITRO AND IN VIVO EVIDENCE FROM THE MOUSE 
 
 
 
 
A Thesis 
Presented to the Faculty of the Department of Physiology 
Brody School of Medicine at East Carolina University 
 
 
 
 
 
In Partial Fulfillment of the Requirements for the Degree 
Master of Science in Biomedical Science 
 
 
 
 
by  
Tracy L. Johnson 
June 2012 
	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Tracy L. Johnson, 2012  
	  DOPAMINERGIC MODULATION OF THE AUTONOMIC NERVOUS SYSTEM:   
IN VITRO AND IN VIVO EVIDENCE FROM THE MOUSE 
 
 
 
by 
Tracy L. Johnson 
 
 
 
 
APPROVED BY: 
 
DIRECTOR OF THESIS    ________________________________ 
        Stefan Clemens, Ph.D. 
 
COMMITTEE MEMBER    ________________________________ 
          Alexander Murashov, M.D., Ph.D. 
 
COMMITTEE MEMBER    ________________________________ 
          Kori Brewer, Ph.D. 
 
COMMITTEE MEMBER    ________________________________ 
          Richard Ray, Ph.D. 
 
CHAIR OF THE DEPARTMENT    ________________________________ 
OF PHYSIOLOGY      Robert Lust, Ph.D. 
 
DIRECTOR OF THE BIOMEDICAL   ________________________________ 
SCIENCE MASTERS PROGRAM   Richard Franklin, Ph.D. 
 
DEAN OF THE GRADUATE SCHOOL  ________________________________ 
        Paul J. Gemperline, Ph.D. 
 
	  DEDICATION 
 
 I dedicate my work in graduate school to my late father, Cecil Edward Denison, 
Jr.  I was a Daddy’s girl from the start and to lose you was the hardest thing I’ve ever 
had to endure.  14 years later and I still think about you every day.  I hope you know 
how much I still love and miss you. 
  
	  ACKNOWLEDGMENTS 
 
 First and foremost, I would like to thank my mentor, Dr. Stefan Clemens, for 
allowing me to work in his lab for the past 2.5 years.  Easy, uncomplicated, and painless 
are not words I would use to describe my years in graduate school. However, Dr. 
Clemens not only welcomed me into his lab, but he made me feel wanted and even 
though things were mostly hard, complicated, and painful (all from my end), he never 
gave up on me.   
 
 I thank my committee, Dr. Stefan Clemens, Dr. Kori Brewer, Dr. Richard Ray, 
and Dr. Alexander Murashov for giving me their time and guidance in this process. 
 
 I thank Dr. Benjamin Keeler for his support and advice, without which I would 
have never been able to finish my degree.  I couldn’t have asked for a better person to 
share the lab with during graduate school. 
 
 I thank my friend, Fatiha Moukdar, who encouraged me every single day of 
graduate school to keep going.  I am leaving North Carolina with two things I didn’t have 
when I came here:  a Master’s Degree and the best friend I’ll ever have.   
 
 I thank the faculty, graduate students, and staff of the Physiology Department, 
particularly Dr. Robert Lust, who greatly facilitated my transfer from the PhD program to 
the Master’s Program. 
 
	   I thank Dr. Richard Franklin and the Biomedical Sciences Masters Degree 
Program for allowing me to complete my degree. 
 
 I thank Jim and Sheryl York and Cecil E. Denison, Jr., for being the best parents I 
could have asked for in my life. 
 
 Last, but not least, I thank my family:  my husband, Matt and children, Nathan 
and Abigail for their love and support during the past 3 years.   
	  TABLE OF CONTENTS 
LIST OF TABLES………..……………………………………….…….……………….............. 
LIST OF FIGURES.…………………………………………….……………………..…………. 
LIST OF ABBREVIATIONS…………………………………..………….…............................ 
CHAPTER 1:  GENERAL INTRODUCTION…………………………….............................1 
 Definitions………….………………………………………………………………..……. 
 Specific Aims………………………………………..……………………………………. 
CHAPTER 2:  METHODS…………..……………………………………………….………..10 
CHAPTER 3:  SEGMENT-SPECIFIC CHANGES IN SPINAL CORD CIRCUITRY 
LEADING TO DIFFERENTIAL DOPAMINERGIC MODULATION OF REFLEXES……22  
 Summary.……………………………………………………………………….………… 
 Introduction.…………………………………………………………………………….… 
 Results.……………………………………………………………………………….…… 
 Discussion.……………………….……………………………………………………….. 
CHAPTER 4:  THE DOPAMINE D3 RECEPTOR KNOCKOUT MOUSE MODELS 
AGING-RELATED CHANGES IN AUTONOMIC FUNCTION…………………..……......73 
 Summary.……………………………………………………………………………….… 
 Introduction.……………………………………………………………….……………… 
 Results.……………………………………………………………………….…………… 
 Discussion…………………………………………………………………………………
CHAPTER 5:  CONCLUSION…….………………………………………..…………… …...99 
REFERENCES.……………………………………………………………………………....103
APPENDIX….……….……………………………...……………………….…………….….117 
	   Animal user protocols..………………………………………………………………….. 
  
	  LIST OF TABLES 
 
CHAPTER 3:  SEGMENT-SPECIFIC CHANGES IN SPINAL CORD CIRCUITRY 
LEADING TO DIFFERENTIAL DOPAMINERGIC MODULATION OF REFLEXES 
Table 3.1 Summary of differential MSR DA responses  
 
CHAPTER 4:  THE DOPAMINE D3 RECEPTOR KNOCKOUT MOUSE MODELS 
AGING-RELATED CHANGES IN AUTONOMIC FUNCTION  
Table 4.1:  Animal weights 
Table 4.2:  Echocardiogram analysis 
Table 4.3:  Morphometric analysis 
  
	  LIST OF FIGURES 
 
CHAPTER 1: INTRODUCTION 
Figure 1.1:  Model of dose-dependent modulation of DA 
 
CHAPTER 2:  METHODS 
Figure 2.1:  Electrophysiology experimental setup 
Figure 2.2:  Typical example of an ultrasound echocardiogram 
 
CHAPTER 3: SEGMENT-SPECIFIC DIFFERENCES IN SPINAL CORD CIRCUITRY 
LEADING TO A REVERSAL OF DOPAMINERGIC REFLEX MODULATION 
Figure 3.1:  Stimulation of the lumbar, thoracic, and sacral dorsal roots evoked short-
latency monosynaptic and longer latency reflex  
Figure 3.2:  Presence of MSR and LLR in thoracic, lumbar, and sacral segments 
Figure 3.3:  DA and DA receptor agonist and antagonist modulation of MSR in lumbar 
and IML-containing segments 
Figure 3.4:  DA and DA receptor agonist and antagonist modulation of LLR in lumbar 
and IML-containing segments  
Figure 3.5:  5-HT and NA modulation of MSR in lumbar and IML-containing segments 
Figure 3.6:  5-HT and NA modulation of LLR in lumbar and IML-containing segments 
Figure 3.7:  MSR response to gap junction blockers in combination with DA and DA 
receptor agonists and antagonists in IML-containing segments 
Figure 3.8:  Potential model for Specific Aim #1 
 
	  CHAPTER 4:  THE DOPAMINE D3 RECEPTOR KNOCKOUT MOUSE MODELS 
AGING-RELATED CHANGES IN AUTONOMIC FUNCTION 
Figure 4.1:  Blood pressure, heart rate, and rate-pressure product of awake WT and 
D3KO animals 
Figure 4.2:  Echocardiogram traces from 2-month-old, 1-year-old, and 2-year-old WT 
and 2-month-old D3KO animals 
Figure 4.3:  Interstitial fibrosis in WT (2 months to 2 years) and young (2 months) D3KO 
animals 
  
	  LIST OF ABBREVIATIONS 
 
5-HT  Serotonin (5-hydroxy-tryptamine) 
ACSF  Artificial cerebrospinal fluid 
ANS  Autonomic Nervous System 
cAMP  Cyclic adenosine monophosphate 
CNS   Central Nervous System 
CPG  Central pattern generator 
D3KO  D3 receptor knockout 
DA  Dopamine 
GI  Gastrointestinal 
IML  Intermediolateral cell column 
LLR   Long-latency reflex 
MCSA  Myocyte cross-sectional area 
MMP  matrix metalloproteinase  
MSR  Monosynaptic reflex 
NA  Noradrenaline 
NIA  National Institutes of Aging 
PNS  Parasympathetic Nervous System 
RLS  Restless Legs Syndrome 
RPP  Rate pressure product 
SEM  Standard error 
SNS  Sympathetic Nervous System 
SPN  Sympathetic preganglionic neuron 
	  SRA  Spinal reflex amplitude 
WT  Wild type 
	   	  
CHAPTER 1:  GENERAL INTRODUCTION 
Spinal Cord and the Autonomic Nervous System 
The central nervous system (CNS) is comprised of the brain and spinal cord and 
has two divisions:  somatic and autonomic, both of which are present in the spinal cord.  
The somatic nervous system innervates skeletal muscle and controls voluntary 
movement, while the autonomic nervous system (ANS) innervates smooth and cardiac 
muscle as well as glands, and controls involuntary functions (adapted from 
www.ndrf.org). The ANS is further subdivided into the sympathetic nervous system 
(SNS) and the parasympathetic nervous system division (PNS). While the components 
of the somatic nervous system are located in each segment of the spinal cord, the ANS 
is represented only in some segments: in humans, the SNS is located in the spinal 
segments T1-L2, while the PNS is located in the brainstem and spinal segments S2-S4 
(Charles Watson, 2008).  These spinal cord segments contain the final common output 
of the autonomic nervous system – the sympathetic preganglionic neurons (SPNs).  The 
specific neuronal circuitry found in each segmental division in the spinal cord is at the 
center of attention for numerous research laboratories, but despite their efforts, spinal 
cord circuitry is still not fully understood.  Identification of the anatomical and functional 
circuitry of the spinal cord has major implications for understanding both neurological 
diseases and injury states.   
 
Nervous System Circuitry for Spinal Reflex 
 One of the simplest neural networks is the monosynaptic reflex (MSR) circuit.  
The coordination of the input and output aspects of this circuit contribute to the 
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contraction and relaxation of a muscle in vivo (Chen et al., 2003).  This careful control of 
the state of the muscle is important during proprioception and helps determine the final 
motor output of spinal motor circuits (Rossi-Durand, 2006).  A reduced spinal cord 
preparation is typically used to study the MSR and other types of reflex activity such as 
long-latency reflex (LLR) in vitro (Clarac et al., 2000, Chen et al., 2003, Rossi-Durand, 
2006).  As demonstrated first by Sherrington, the circuits for spinal reflex can be 
manipulated by descending systems to produce complex voluntary movements 
(Sherrington, 1906, 1910).  However, reflex systems do not simply act in the 
background to perform the task of local regulation of voluntary movements that are 
more or less directly executed by descending systems; reflexes can be functional 
outside of the influence of the brain, and the spinal cord is by itself capable of producing 
not only reflexes, but also the coordinated, rhythmic movements of locomotion (McCrea, 
1986). Importantly, spinal reflexes can be modulated by different pharmacological 
substances such as serotonin, noradrenaline, dopamine, glutamate, GABA, etc. (Carp 
and Anderson, 1982, Hounsgaard and Kiehn, 1989, Tanabe et al., 1990, Crick and 
Wallis, 1991, Kiehn et al., 1999, Levant and McCarson, 2001, Machacek et al., 2001, 
Clemens and Hochman, 2004, Clemens et al., 2006, Juvin et al., 2007, Lapointe et al., 
2009, Clemens et al., 2012). As such, reflex modulation is an indication of the changes 
that can be imposed onto the hard-wired circuits in the spinal cord and that can 
effectively shape different behavioral outcomes to meet the needs of the animal (Marder 
and Calabrese, 1996, Clemens, 1998, 2011, Marder, 2011). 
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Dopamine 
Dopamine (DA) is a monoaminergic neurotransmitter discovered over 50 years 
ago by Avid Carlsson, which has been shown to have wide-reaching effects in many 
areas of the body, including the brain, spinal cord, and organ systems outside of the 
CNS, such as the heart and kidney (Carlsson and Waldeck, 1958, Adam, 1980, 
Lokhandwala and Amenta, 1991, Jaber et al., 1996, Ozono et al., 1996, Ricci et al., 
1998, Hussain and Lokhandwala, 2003, Banday and Lokhandwala, 2008).  The actions 
of DA are widely studied in the CNS, primarily in the brain, where it plays a major role in 
reward-driven learning, motor control, and cognition, along with many other functions 
(Jaber et al., 1996); less studied are the effects of DA in the spinal cord.  Evidence 
suggest that all DA neurons are located in the brain, but DA fibers also descend from 
the brain into the spinal cord exclusively from a small DA cluster in the A11 region of the 
dorsal hypothalamus (~150 neurons in the mouse, 300 in rat).  They project extensively 
through the entire cord, including the deep dorsal horn, responsible for pain perception, 
the intermediolateral nucleus (IML), the final common output of the sympathetic nervous 
system, and the motoneuron pools, which control leg locomotor output (Bjorklund and 
Skagerberg, 1979, Skagerberg et al., 1982, Lindvall et al., 1983, Skagerberg and 
Lindvall, 1985, Holstege et al., 1996). Despite this well-established DA projection 
pattern, few studies have examined the modulatory actions of DA in the spinal cord. 
These studies have shown that DA can have effects on unidentified neurons in the IML 
that are slow and long lasting, and they can be inhibitory, excitatory or mixed, pointing 
to the modulatory potential of DA (Gladwell and Coote, 1999b, Gladwell and Coote, 
1999a).  The studies also revealed that the DA-induced inhibitory actions are controlled 
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by a direct membrane activation, whereas the excitatory actions are synaptically-
mediated (Gladwell and Coote, 1999a).  The first complete map of DA receptor 
expression and distribution in the rodent spinal cord was completed recently (Zhu et al., 
2007) and it was reported that, in the lumbar spinal cord, all DA receptors are present 
throughout the spinal gray matter, and that at least a subset of motoneurons contains 
both D1 and D2 receptors alike.  DA acts through two different receptor subfamilies, D1-
like (D1, D5) and D2-like (D2, D3, D4) and has a lower affinity for the D1-like receptors 
compared with the D2-like receptors (Fig 2.1).  There is mounting evidence that spinal 
neurons may be able to react to DA in a dose-dependent manner due to the differing 
affinities of DA receptors towards DA (Clemens et al., 2012). 
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Model of Dose-Dependent Modulation of DA 
 
Figure 1.1 
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Figure 1.1 Legend 
The affinity of the different receptor subtypes towards DA is D2-like >> D1-like.  Thus 
under low DA conditions, DA will bind first to D2-like receptors, which tend to mediate 
overall inhibitory actions.  At higher levels of DA, additional D1-like receptors will be 
activated, which generally mediate excitatory effects. 
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 Studies on DA-mediated effects on spinal cord function have focused almost 
exclusively on the lumbar segments and the role DA may play in the recruitment of the 
central pattern generator (CPG) for locomotion.  Recruitment of the CPG appears to 
occur at higher of DA concentrations (Cazalets et al., 1995, Han et al., 2007), 
presumably via D1-like receptor pathways (Han and Whelan, 2009).  DA has also been 
shown to directly modulate spinal reflex in the lumbar segments of the spinal cord (L2-
L5) (Clemens and Hochman, 2004).  Together these data suggest that individual 
motoneurons in the spinal cord can adjust their output as a function of ambient DA 
release.   
 
Specific Aim #1: 
 Test the hypothesis that dopamine modulates autonomic and somatic circuits 
differently in vitro.   
 Problem:  Most studies focused on DA action in the spinal cord have focused on 
dopaminergic changes in spinal reflex only in the lumbar segments of the cord, and until 
this point it has been unknown if segments containing autonomic innervation have a 
similar change in reflex amplitude with the addition of DA.   
 Hypothesis:  Changes in reflex amplitude in different segments of the spinal cord 
mediated by dopamine are dependent on the presence or absence of the ANS. 
 Approach:  In the first part of this study, we studied the role of DA in modulating 
spinal reflex.  Experimentally, monosynaptic and long-latency reflexes (MSR and LLR) 
are evoked in an in vitro rodent spinal cord preparation and dopamine is bath applied to 
observe a drug-dependent change in reflex (MSR, LLR, or both).  Our study sought to 
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uncover if there might be segment-specific differential dopaminergic modulation of 
spinal cord reflex in thoracic, lumbar, and sacral segments of the mouse. 
 
Aging-related Changes in Autonomic Output 
In Specific Aim #1, we wanted to determine if DA would have different effects on 
spinal reflex in segments of the spinal cord with and without autonomic innervation 
using an in vitro approach.  We next asked the question if a DA effect on the autonomic 
nervous system would also be relevant in vivo.  Along with a clear role in the CNS and 
in modulating spinal cord reflexes, DA is also known to be involved in the development 
of hypertension and DA receptor populations are present in both the heart and the 
kidney (Adam, 1980, Lokhandwala and Amenta, 1991, Jose et al., 1992, Ozono et al., 
1996, Ricci et al., 1998, Cavallotti et al., 2010).  In particular, a role for the D3 receptor 
has been suggested in the increased blood pressure (Jaszlits et al., 1985, Jose et al., 
2002, 2003, Polakowski et al., 2004, Yang et al., 2004, Zeng et al., 2004a, Staudacher 
et al., 2007).  Interestingly, a genetically modified knockout animal for this receptor 
(D3KO) exhibits both hyperactivity and hypertension (Asico et al., 1998).  The D3KO 
mouse has been introduced as a potential animal model for the sensory-motor and 
sleep disorder Restless Legs Syndrome (RLS)(Clemens et al., 2006, Paulus et al., 
2007).  Patients suffering from this disorder often also express hypertension 
(Winkelman, 1999, Hening et al., 2007, Winkelman et al., 2008, Walters and Rye, 2010) 
and RLS pathology and associated symptoms worsen with age (Ferri et al., 2008). In 
humans, treatment with D3-receptor agonists can remediate both RLS symptoms and 
the associated hypertension (Manconi et al., 2010). These findings then underline the 
	   9	  
possibility that the D3 receptor system may play a pivotal role in the emergence of 
aging-related hypertension. While a recent study suggested a role of intrarenal DA 
deficiency on hypertension and decreased longevity (Zhang et al., 2011), in that effort 
the role of the D3 receptor was not addressed. 
 
Specific Aim #2: 
 Test the hypothesis that in vivo ANS function is under DA modulatory influence.  
 Problem:  Aging animals and humans exhibit increased blood pressure over the 
course of a lifetime.  If the D3KO mouse shows an early increase in blood pressure, this 
animal could be used as a new model for advanced aging.  
 Hypothesis:  The D3 receptor plays a key role in regulating global autonomic 
tone and the loss of this receptor will result in early-onset hypertension. 
 Approach:  To study the role of DA on changes in cardiovascular components of 
the ANS, in vivo measurements of blood pressure, heart rate, functional 
echocardiography, and post-mortem fibrosis measurements are done on the aging WT 
mouse vs. the D3KO mouse.  The results will show how a system-wide knockout of the 
functioning D3 receptor will affect the animal in terms of regulation of the ANS. 
 
  
	  CHAPTER 2:  METHODS 
All experimental procedures were reviewed and approved by the Institutional 
Animal Care and Use Committee of East Carolina University according to the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals (US NIH, Pub. No. 
85-23, rev. 1996). Copies of the approval notices are submitted in the Appendix.  
 
In vitro Electrophysiology Experiments 
Animals  
A total of 80 wild type mice (C57BL/6) of either sex (postnatal day 5 to 14) were 
anesthetized with an i.p. injection of a ketamine/xylazine mix (18mg/ml and 2mg/ml at 
0.05 ml/10g body weight).  The spinal cord was quickly dissected and placed in a 
Sylgard-lined (Dow Corning, Midland, MI) Petri dish in ice-cold sucrose artificial 
cerebrospinal fluid (ACSF) containing: sucrose 87g/L, D-glucose 4.5g/L, NaHCO3 2.2 
g/L, KCl 0.19g/L, NaH2PO4 0.17g/L, MgCl2 0.15g/L, CaCl2 0.04g/L at a pH of 7.4, 
aerated with 95% O2/5% CO2. After the dura mater was opened (usually within 10 
minutes of decapitation), the high sucrose-ACSF was washed out against regular ACSF 
containing: 7.5g/L NaCl, 0.14g/L KCl, 0.35g/L CaCl2, 0.32g/L MgCl2, 1.8g/L glucose, 
0.16g/L KHPO4, and 2.2g/L NaHCO3 at a pH of 7.4, and oxygenated with 95% O2/5% 
CO2.   
To record reflexes and to avoid interference from the cross-extension reflex 
circuitry, spinal cord preparations were hemisected mid-sagittally, which also served to 
better oxygenate the tissue and allow for better access of ACSF.  Dorsal and ventral 
roots were identified and pinned out as needed with small Minutien pins (Fine Science 
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Tools, Foster City, CA). Glass suction electrodes were placed on the dorsal and 
ventral roots of thoracic segments (T6-T13), lumbar segments (L1-L6), or sacral 
segments (S1-S2).  Stimulations and recordings were either done with two sets of 
recordings in parallel (e.g. one dorsal stimulus/ventral recording on a thoracic segment 
and one dorsal stimulus/ventral recording on a lumbar segment), or with one segment 
(e.g. one dorsal stimulus/ventral recording on a sacral segment)(see Fig 2.1).  Dorsal 
roots were stimulated with constant current pulses of 50–500 µA, and a duration of 50–
500 µs, at interstimulus intervals of 30–60 s.  Reflex responses were recorded from the 
corresponding ventral roots and amplified with a four-channel extracellular AC amplifier 
(AM-Systems, Model 1700, Sequim, WA), and digitized with a Digidata 1322A, using 
pClamp 10.2 software (Axon Instruments, Union City, CA). To allow comparisons, reflex 
responses were rectified, and the calculated integrals of these responses were 
measured and compared between epochs of identical duration before and after drug 
application. Reflex amplitudes were normalized to the mean of the control values and 
are reported here as percentage changes from the control (pre-drug) conditions.  
Comparisons were made between the averaged amplitudes of the last 10 consecutive 
reflex responses measured before drug application and the averaged amplitudes of the 
last 10 consecutive reflex responses during the drug application. 
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Electrophysiology Experimental Setup 
A 
 
 
 
 
B 
 
Figure 2.1 
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Figure 2.1 Legend 
 
A. This photograph shows the Faraday cage setup for an in vitro electrophysiology 
experiment.  The Faraday cage contains the dissecting microscope and the petri dish 
with the spinal cord hemisects in ACSF.  Two pair of electrodes (two stimulating and 
two recording) are attached to matching dorsal and ventral roots of different segments 
of the spinal cord in order to record reflex activity.   
B. This photograph shows the typical setup for an in vitro electrophysiology experiment.  
Shown are two hemisects of the same spinal cord, with the dorsal roots positioned on 
the left and the ventral roots positioned on the right.  Two pairs of stimulating electrodes 
are attached to the dorsal roots on the left and two pairs of recording electrodes are 
attached to the ventral roots on the right.  With this preparation, we can easily record 
from different segments in the same experiment. 
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Pharmacology  
After a stable response in the ventral root recordings was established, typically 
30–60 min after onset of the stimulation protocol, drugs (drug-dependently dissolved in 
distilled water or ethanol) were bath applied for durations of 30-60 min.  The following 
chemicals were used in this part of the study: Dopamine (1 µM, together with 9 mM 
sodium meta-bisulfite, used as an antioxidant, both from Sigma-Aldrich).  The DA 
receptor agonists applied included: quinpirole (D2 receptor agonist, 1 µM; Tocris 
Bioscience), raclopride (D2 receptor antagonist, 10 µM; Sigma-Aldrich), and SKF38393 
(D1 receptor agonist, 10 µM; Tocris Bioscience).  We also tested the effects of the other 
monoamines, noradrenaline (10 µM; Sigma Aldrich) and serotonin (5-HT, 10 µM; Tocris 
Bioscience). In addition to the monoamines, we also tested the effects of the gap 
junction blockers carbenoxolone (100 µM; Aldrich Chemical) and quinine (10 µM; Sigma 
Aldrich). Tests of the effects of the individual drug carrier substances or antioxidants 
(ethanol or Na2S2O5) at their final concentrations used in the experiments did not lead to 
any of the effects on reflex modulation that were observed with the additional presence 
of the respective drug (data not shown). 
Several drugs were often compared in the same animal.  In these cases, 
following the drug application, we interrupted the stimulation protocol and washed the 
preparation (three to four times the bath volume over a 3–5 min period) with room 
temperature ACSF and subsequently let the preparation recover from the drug 
application for an additional 30-60 min.  During this time, we repeated the stimulation 
protocol to assure the recovery of the reflex responses.  In general, reflex responses 
returned to pre-drug amplitudes, and these “recovered” reflex amplitudes in turn 
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became the pre-drug control of the subsequent drug application. With this protocol we 
were able to test several drugs per experiment. 
 
Statistical Analysis 
All values are given as mean ±SEM.  We used SigmaPlot 11.0 (SPSS Science, 
Chicago, IL) to analyze the data and test for significant differences in the course of an 
experiment using parametric or nonparametric tests where appropriate.  Differences 
were considered significant if p<0.05. 
 
In vivo Autonomic Evaluation and Histology 
Animals 
A total of 42 animals were used across all the in vivo experiments addressing the 
role of DA on autonomic function and with aging.  Wild type (WT) mice (C57BL/6) were 
divided into three separate age groups: 2-3 month-old (n=10), 1-year-old (12-14 months, 
n=12), and 2-year-old mice (24-27 months, n=10).  2-month- and 1-year-old WT animals 
had been bred and kept on site, 2-year-old mice were obtained from the National 
Institutes of Aging (NIA). D3 receptor knockout (D3KO) animals on a C57BL/6 
background (B6.129S4-Drd3tm1Dac/J) were obtained from Jackson Laboratory, Bar 
Harbor, ME, and maintained as a breeding colony at ECU. Animals were housed in the 
Brody School of Medicine Animal Facility with a 12:12-h light-dark cycle and free access 
to standard mouse chow and water.  
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Blood Pressure Measurements 
Systolic and diastolic blood pressure and heart rate in awake mice were 
measured using a noninvasive tail cuff measurement system (Model SC1000 Blood 
Pressure Analysis System, Hatteras Instruments, Cary, NC). Animals were placed on a 
warming platform with a temperature of 37-38° C for comfort, and a magnetic metal 
holder was used to restrict movement that could potentially affect readings. A traditional 
tail-cuff occluder was placed proximal on the mouse’s tail, which was then immobilized 
with tape in a V-shaped block between a light source above and a photoresistor below 
with a LED assembly to detect the pulse. The tail was carefully taped at the tip to 
prevent the mice from pulling out of the cuff. Data were displayed, recorded, and stored 
for analysis on a PC (SC1000 Comm Windows, v2.50) and were exported and saved to 
SigmaPlot (v11; Systat Software, Inc., Chicago, IL) for analysis. The minimum pulse 
amplitude was set to 20%, the systolic threshold to 5%, and the maximum pressure to 
occlude blood flow in the tail to 200 mmHg.  
Measurements took approximately 8 minutes to complete and consisted of 5 
preliminary cycles and 10 measurement cycles.  The preliminary cycles served to 
acclimate the mice, while the subsequent cycles provided the measurements for systolic 
and diastolic blood pressure and heart rate.  Each cycle included two phases: pulse 
detection and blood pressure acquisition.  Pulse detection took ~10 seconds once 
animals were properly acclimated and systolic/diastolic pressure readings took ~20 
seconds.  The warming platform was cleaned after each session to remove any odors 
and minimize stress for subsequent animals.  Measurements were performed on 
sequential days and at similar times to maintain consistency and to avoid circadian 
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perturbations.  Only animals of the same age group or strain were measured on a given 
day, and recording sessions were repeated daily, generally for 4-6 days.  Further, to 
avoid potential problems stemming from the acclimation phase during the first sessions, 
we only analyzed data from the last 3 sessions per animal.  These readings were then 
averaged to produce a single data point for each session, for systolic and diastolic blood 
pressure, and heart rate, respectively. 
 
Functional Echocardiography  
Left ventricle echocardiograms of the 3 differently aged WT and the young D3KO 
animals were taken with the Vevo 2100 Imaging system (VisualSonics, Toronto, ON, 
CA) and the data analyzed off-line. Animals were anesthetized by exposure to 2% 
isoflurane and were placed on a platform under a fumehood, where the anesthesia was 
maintained via a nose cone. The chests were depilated with a chemical hair remover to 
minimize ultrasound attenuation, and a contact gel (Aquasonic, Parker Laboratories, 
Fairfield, NJ) was applied to the thorax surface to optimize visibility of the heart and the 
left ventricle. Parasternal long- and short-axis views were acquired in M-mode traces 
made from B-mode images.  In order to obtain and calculate the measurements of the 
different parameters, the LV area tool was used to trace the anterior and posterior walls 
of the left ventricle. After the tracings were completed, the imaging software calculated 
the following parameters: Heart Rate (BPM), Volume (systolic, µl), Volume (diastolic, µl), 
Stroke Volume (µl), Ejection Fraction (%), Fractional Shortening (%), Cardiac Output 
(ml/min), Diameter (systolic, mm), Diameter (diastolic, mm), LV mass (mg), LV mass / 
body weight (mg)(See Fig 2.2). 
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Typical Example of an Ultrasound Echocardiogram 
 
 
 
Figure 2.2 
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Figure 2.2 Legend 
 
The LV area tool (blue line) was used to trace the anterior and posterior walls of the left 
ventricle.  The anterior wall is labeled AW and the posterior wall is labeled PW in this 
example.   The green lines show the internal dimension of the systolic diameter and the 
red lines show the internal dimension of the diastolic diameter as calculated by the Vevo 
2100 system.   
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Tissue Harvesting and Histology 
After the in vivo data were acquired, animals were deeply-anesthetized by 
exposure to urethane and decapitated, the hearts quickly dissected out, fixed in zinc-
based fixative (n=5 per group and strain), processed, and embedded according to 
routine procedures for histological analyses (Dries et al., 2011). 
Slides stained with hematoxylin and eosin were used for morphometric analysis 
of left ventricular area, chamber area, and myocyte cross-sectional area (MCSA). Briefly, 
for ventricular and chamber areas, each of the 4 sections per heart were imaged at 20x, 
the measures were averaged per animal, and each of those averages were used to 
calculate the average for all 5 hearts in each group. For MCSA, 3 images in both the 
epicardial and endocardial regions of 2 sections per hearts were taken. In each image, 
the area of 3-8 myocytes with centrally located nuclei was measured and recorded. The 
average of these numbers were calculated for each animal and then those numbers 
were averaged for n=5 per group (Virag et al., 2010). 
 
Fibrosis Staining   
Picrosirius Red Protocol was performed according to routine procedures. Briefly, 
slides were de-paraffinized and rehydrated, immersed in a 0.1% picrosirius red/fast 
green solution (Sigma-Aldrich, 365548, F7258, P6744) for 30 min, cleared and 
coverslipped (Virag et al., 2007). Tissue collagen was determined by taking 4 images at 
400x in 2 sections per heart and using Adobe Photoshop to count the number of red 
and green pixels. The percent collagen was calculated as the number of red pixels/red + 
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green pixels x 100%, the numbers were averaged for each animal, and the data 
presented are the average of 5 animals per group.  
 
Statistical Analysis 
All data are presented as means ± standard error (SEM).  SigmaPlot 11 (Systat 
Software, Inc., Chicago, IL) was used to analyze data and to test for significant 
differences in the course of an experiment.  ANOVA was performed on data at a 
minimum p<0.05 threshold, and appropriate post-hoc tests were applied to evaluate 
differences between treatment groups.
 
 
 
	  CHAPTER 3: SEGMENT-SPECIFIC DIFFERENCES  
IN SPINAL CORD CIRCUITRY LEADING TO A REVERSAL OF  
DOPAMINERGIC REFLEX MODULATION 
SUMMARY 
Dopamine (DA) innervation is thought to be present in the entire segmentally 
organized spinal cord, where DA’s actions are mediated by D1- and D2-like receptors 
alike. However, the modulatory actions of DA in the different regions of the spinal cord 
are poorly understood and research has focused on lumbar segments L3-L5 and their 
role in locomotion or reflex modulation. In contrast, the action of DA in those spinal cord 
segments that house the autonomic nervous system (ANS, T1-L2 and, in mouse, L6-
S1) have not been addressed. Using electrophysiological and pharmacological 
approaches of the isolated neonatal spinal cord in vitro, we provide evidence that DA 
modulation of the spinal reflex circuitry exerts opposing modulatory effects in the mouse 
spinal cord, and that these differences coincide with the presence or absence of the 
ANS. In particular, bath-application of low DA levels and D2-receptor agonists 
decreased spinal reflex responses in the L3-L5 segments, but significantly facilitated 
them in the thoracic and sacral segments studies. Conversely, D1-receptor activation 
facilitated reflex responses in L3-L5, but decreased them in the ANS-containing 
segments. 
Further, the region-specific modulatory effects were specific for dopaminergics. 
While bath-application of other monoamines (serotonin and noradrenaline) was able to 
modulate spinal reflex amplitudes, we did not find any region-specific differences as 
was found with the dopaminergics.
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 As gap junctions play an important role in the interneuronal communication in 
both the ANS and between motoneurons, we decided to test if they might also be 
involved in the location-specific modulation under DA. Application of both 
carbenoxolone and quinine reversed the reflex DA-modulation of responses in ANS-
containing spinal segments, but had no additional effect in L3-L5 segments. 
Thus our data suggest that DA modulates the spinal reflex circuitry in a region-
specific manner, dependent on the presence or absence of the ANS, and that these 
actions might be mediated via gap junctions. 
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INTRODUCTION 
Understanding the circuitry of the spinal cord is essential for understanding the 
global function of the spinal cord not only under normal circumstances, but also 
following changes that occur in the injury or disease state.  In this study, we address 
monoaminergic-mediated changes in activity between sensory, motor, and autonomic 
neuronal cell populations in the spinal cord.   
The study of spinal reflex is one tool that can be used to understand the circuitry 
of the spinal cord (Pinco and Lev-Tov, 1993, Chen et al., 2003).  Two broad divisions 
can be made when assessing reflex activity:  The monosynaptic reflex (MSR) is two 
neuron pathway: a large-diameter sensory Aα neuron originating from a muscle spindle 
receptor directly synapses upon α motoneurons in the spinal cord, which project 
homosynaptically and monosynaptically to the muscle containing the Aα neuron.  The 
simplicity of connection between these two cells makes it the most well studied spinal 
reflex (Frank and Mendelson, 1990, Davidoff, 1992, Pierrot-Deseilligny and Mazevet, 
2000, Voerman et al., 2005, Rossi-Durand, 2006).  
In contrast, polysynaptic, or long-latency reflexes (LLR) likely follow a different 
path and they are mediated by more than two neurons.  LLR can be produced by 
several possible mechanisms:  activation of small-diameter afferent fibers (Aδ and C) 
evoked by high intensity stimuli, repetitive firing of motoneuron pools, or activation of 
interneuronal pathways can all contribute to the generation of the LLR (Clemens and 
Hochman, 2004).  The circuitry of both types of reflex activity can be studied in detail 
with an in vitro isolated neonatal rodent spinal cord preparation; in this model MSR and 
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LLR amplitude, once stabilized, can be modulated by the addition of drugs to the 
preparation (Fulton, 1986, Jiang et al., 1999).  See Fig 3.1. 
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Stimulation of the lumbar, thoracic, and sacral dorsal roots evoked short-latency 
monosynaptic and longer latency reflex.   
 
 
 
Figure 3.1 
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Figure 3.1 Legend 
The monosynaptic reflex (MSR) was measured at 3-5 ms from the end of the stimulus 
artifact.  A baseline of amplitudes of the MSR was established as a control before drugs 
were applied to the bath.  Longer latency reflexes (LLR) were measured from the end of 
the MSR and following a typical 2-5 ms period of inactivity until approximately 65 ms 
following the onset of reflex activity. 
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 Monoamines are one class of neurotransmitters known to modulate spinal cord 
function, including MSR and LLR (Kitazawa et al., 1985, Lew et al., 1992, Tanaka et al., 
1997, Kiehn et al., 1999).  Serotonin (5-HT) and noradrenaline (NA) have been studied 
in detail in this context, but the role of spinal dopamine (DA) is still not as well 
characterized as the other monoamines (Garraway and Hochman, 2001, Clemens and 
Hochman, 2004).  The only source of spinal DA is the A11 cell group in the dorsal 
posterior hypothalamus, which sends projections to most locations in the spinal cord 
(Skagerberg et al., 1982, Lindvall et al., 1983, Skagerberg and Lindvall, 1985, Holstege 
et al., 1996).  A recent study in a non-human primate (the macaque monkey) suggests 
that DA itself is not projected from the A11 cell group, but instead the precursor to DA, 
L-DOPA, travels from the brain to the spinal cord, where L-DOPA can be converted to 
DA (Barraud et al., 2010).  All DA receptors (D1-D5) have been found in all lamina of 
the spinal cord and the activation of these specific DA receptors mediate downstream 
effects on spinal cord reflex (van Dijken et al., 1996, Gladwell and Coote, 1999b, 
Gladwell et al., 1999, Levant and McCarson, 2001, Zhu et al., 2007).  There are two 
families of DA receptors:  D1-like receptors (D1, D5), which tend to induce excitatory 
actions (increasing intracellular levels of cAMP), and D2-like receptors (D2, D3, D4), 
which generally activate inhibitory second messenger pathways (Carp and Anderson, 
1982, Gajendiran et al., 1996).  The DA system is present at birth, allowing the neonatal 
rodent spinal cord preparation to be useful in studying dopaminergic reflex modulation 
(Kudo and Yamada, 1985, Reisert et al., 1990). Both the presence of DA and DA 
receptors throughout the spinal cord indicate that dopamine can impact the functional 
output of this system.  
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Studies on the role of DA in modulating spinal reflex have primarily focused on its 
action in the lumbar segments of the spinal cord (Clemens and Hochman, 2004, Juvin 
et al., 2007).  This information is useful in examining the circuitry involved in locomotion; 
however, there are other segments with different populations of neurons that could be 
influenced by dopaminergic reflex modulation.  For example, in humans, the spinal cord 
has autonomic innervation from segments T1-L2 (sympathetic) and from S2-S4 
(parasympathetic).  In mice, the segmental organization of this innervation differs 
slightly with respect to parasympathetic innervation, with autonomic cell bodies located 
from L6-S1.  The presence of these cell types opens up the possibility for reflex circuit 
modulation that is not seen in the segments that lack autonomic input (in mice, L3-L5).    
In search for a possible mechanism for the interaction of spinal somatic and 
autonomic motoneurons, there is evidence that neurons exiting the spinal cord and 
originating in the IML (sympathetic preganglionic neurons – SPNs) are connected to 
each other electrically via gap junctions.  The same study found populations of 
motoneurons are also electrically coupled (Marina et al., 2008).  “A homeodomain 
transcription factor, Hb9, is expressed by embryonic motoneurons and functions during 
development to consolidate motoneuron identity” (Arber et al., 1999, Thaler et al., 1999, 
Wilson et al., 2005).  Cells expressing Hb9 include ventral motoneurons and 
sympathetic preganglionic neurons found in the intermediolateral cell column and the 
central autonomic area, suggesting these cells stem from the same pool during 
development (Wilson et al., 2005).  This information, added to the fact that the individual 
populations of somatic and autonomic motoneurons are coupled electrically, led us to 
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ask if it is possible for the population of motoneurons and sympathetic/parasympathetic 
preganglionic neurons might also be connected to each other via gap junctions. 
The goal of this study is to test the potential role of the ANS in modulating spinal 
reflexes.  More specifically, we are interested in how DA can modulate spinal reflex in 
segments of the spinal cord containing ANS innervation, a novel idea that has not yet 
been explored in other laboratories studying spinal cord reflex circuitry.    
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RESULTS 
Reflexes were analyzed from a total of 80 hemisect spinal cords.  Electrical 
current stimulation of the lumbar, thoracic, and sacral dorsal roots evoked both a short-
latency monosynaptic reflex (MSR) and a longer-latency reflex (LLR).  The MSR was 
identified and measured at 3-5 ms after the end of the stimulus artifact (Clemens and 
Hochman, 2004), Fig. 3.2.  A baseline of spinal reflex amplitudes (SRAs) was 
established as a control before drugs were applied to the bath. LLRs emerged generally 
10-15 ms after the end of the stimulus artifact and lasted for approximately 50-65 ms. 
LLRs were inherently more variable than MSRs and could not be recruited in all 
experiments, thus providing a smaller dataset than the MSRs. 
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Presence of MSR and LLR in Thoracic, Lumbar, and Sacral Segments 
 
Figure 3.2 
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Figure 3.2 Legend 
Both MSR and LLR could be evoked in thoracic, lumbar, and sacral segments.  Traces 
shown are from raw data generated in each of the respective segments shown (T13, L4, 
and S1).  Roots are stimulated on the dorsal side and recorded on the ventral side.  The 
MSR is visible within 10ms of the stimulation artifact and last from 3-5ms in duration.  
The LLR follows a 2-5ms period of quiet activity and can last for hundreds of 
milliseconds. 
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Effect of Dopaminergics on the MSR 
 In order to study the effects of DA and DA-receptor ligands on the MSR 
amplitude between segments of the spinal cord with and without the IML, we bath-
applied the following compounds: 1 µM DA (considered a low concentration), 1 µM 
quinpirole (D2 agonist), 10 µM raclopride in combination with 1 µM DA (D2 antagonist), 
and 10 µM SKF 38393 (D1 agonist).  See Fig 3.3. 
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DA and DA Receptor Agonist and Antagonist Modulation of MSR in  
Lumbar and IML-containing Segments 
 
 
Figure 3.3 
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Figure 3.3 Legend 
A. Application of 1 µM DA to the bath led to a decrease from baseline that was not 
significance in the lumbar segments (L3-L5) of the spinal cord (left bar, n=8).  
Application of 1 µM DA to the bath led to an increase in MSR amplitude from baseline 
measurement in the segments of the spinal cord containing IML (T1-L2, L6-S1) leading 
to an overall increase in amplitude from baseline (right bar, n=26).  The difference in 
MSR amplitude response to 1 µM DA application between the lumbar segments of the 
spinal cord with no IML compared to all segments with IML was significant. 
B.  In lumbar segments (L3-L5) of WT mice, with the application of 1 µM quinpirole, the 
reflex amplitude was decreased from baseline in all experiments (left bar, n=8).  In IML-
containing segments (T1-L2, L6-S1), however, had an overall change from baseline that 
was not significant (right bar, n=7).  The difference in MSR amplitude response to 1 µM 
quinpirole application between the lumbar segments (L3-L5) of the spinal cord with no 
IML compared to all segments with IML was significant. 
C.  The application of 10 µM raclopride and 1 µM DA to lumbar segments (L3-L5) of WT 
mice produced an overall increase significant in reflex amplitude from baseline (left bar, 
n=12).  In contrast, IML-containing segments (T1-L2, L6-S1) had an overall decrease in 
reflex amplitude in response to this drug combination (right bar, n=12).  The difference 
in MSR amplitude response to 10 µM raclopride and 1 µM DA application between the 
lumbar segments of the spinal cord with no IML compared to all segments with IML was 
significant. 
D.  The application of 10 µM SKF 38393 to lumbar segments (L3-L5) caused an overall 
increase from baseline in the lumbar segments (left bar, n=14).  Conversely, the 
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application of 10 µM SKF 38393 to thoracic and sacral segments of the spinal cord 
produced no significant change from baseline (right bar, n=6).  The difference in MSR 
amplitude response to 10 µM SKF 38393 application between the lumbar segments of 
the spinal cord compared to thoracic/sacral segments of the cord was significant. 
 
* = different from baseline 
# = different from effects on lumbar segments  
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Effect of low dopamine  
 Application of 1 µM dopamine (DA) in the lumbar segments (L3-L5) caused in 6 
of 8 applications a depression of the MSR amplitude (-10±5% of control) and in 2 of 8 
applications an increase in the reflex amplitude (10±1% of control).  The overall effect of 
the application of 1 µM DA was no significant change from baseline (-6±5% of control, 
p<0.052)(Fig 3.3A, first bar).  
 In contrast, in IML-containing spinal segments (T1-L2, L6-S1), application of 1 
µM DA to the bath led to an increase in MSR amplitude from baseline measurements in 
20 of 26 applications (18±4% of control).  In 6 of 26 applications, the MSR showed a 
decrease from baseline (-6±1% of control)(Fig 3.3A, right bar), leading to an overall 
significant increase in amplitude from baseline (13±3% of control, p<0.001).   
 The difference in MSR amplitude response to 1 µM DA application between the 
lumbar segments of the spinal cord with no IML compared to all segments with IML was 
significant (p<0.01). 
 
Effect of the D2 receptor agonist quinpirole  
 In order to further explore the differential dopaminergic modulation of MSR 
between non-IML and IML-containing segments, we tested the effects of a D2-preferring 
agonist quinpirole on spinal reflex amplitude (Fig 3.3B).  D2-like receptors (D2, D3, and 
D4) have a higher affinity to DA than D1-like receptors (D1, and D5), and quinpirole has 
been reported to have a 30 times higher affinity to D2 over D3 receptors when cloned 
from human tissue (Sokoloff et al., 1990, Freedman et al., 1994, Sautel et al., 1995) and 
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a 10 times higher affinity to D2 over D3 receptors when cloned from rat tissue (Sokoloff 
et al., 1990, Sautel et al., 1995, Clemens and Hochman, 2004).   
 We found that, in lumbar segments (L3-L5), application of 1 µM quinpirole 
mimicked the effect of 1 µM DA and decreased the MSR amplitude in 8 of 8 
experiments (-17±4% of control, p<0.001)(Fig 3.3B, left bar).   
 In contrast, in IML-containing segments (T1-L2, L6-S1), quinpirole caused in 5 
out of 6 applications an increase in reflex amplitude (21±9% of control), and in only 1 
application a decrease from baseline (-18±6% of control).  The overall change from 
control was an increase by 16±9% (p<0.11)(Fig 3B, right bar).  
 The difference in MSR amplitude response to the application of quinpirole 
application between the lumbar segments (L3-L5) and IML-containing segments with 
IML was significant (p<0.02). 
 
Effect of the D2 receptor antagonist raclopride on the MSR  
 Next, we asked if blocking the D2 receptor could reverse the effect see with both 
1 µM DA and the D2 agonist quinpirole.   The D2 receptor antagonist, raclopride (10 
µM), applied in combination with 1 µM DA to better reveal the consequences of D2 
receptor inactivation, was added to non-IML and IML-containing segments (Fig. 
3.3C)(Lidow et al., 1989, Clemens et al., 2012). 
 The combined application of raclopride and DA to lumbar segments (L3-L5) of 
WT mice produced a significant increase in MSR amplitude over baseline control (70 
±39% of control, p<0.003), with 2 of 12 applications showing a decrease from baseline 
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(-7±3% of control) and 10 of 12 applications showing an increase in reflex amplitude 
from baseline (85±45% of control)(Fig 3.3C, left bar).   
 In contrast, IML-containing segments (T1-L2, L6-S1) showed a consistent and 
significant decrease in reflex amplitude in response to this drug combination (-17±6% of 
control, p<0.003)(Fig 3.3C, right bar).  In 10 of 12 applications the MSR amplitude 
decreased (-22±6% of control), and was not altered in 2 experiments (8±8% of control).  
 As with the application of the D2-agonist quinpirole, application of raclopride 
caused significantly different responses in MSR amplitude modulation between L3-L5 
and IML-containing spinal segments (p<0.001). 
 
Effect of D1 receptor agonist SKF 38393  
 We have seen that differences between the dopaminergic modulation of spinal 
reflex exist between IML and non-IML containing segments.  Next, we tested if this was 
only mediated via the D2 receptor, or if the other class of DA receptors would have the 
same effect.  SKF 38393 is a D1 receptor agonist and has been shown to stimulate 
cAMP production (Setler et al., 1978).   
 Application of SKF 38393 (10 µM) to the lumbar segments L3-L5 significantly 
increased the MSR amplitude from baseline in 12 out of 14 applications (by 31±10% of 
control). In 2 of 14 applications, the reflex amplitude was decreased (by -13±0.08% from 
control). In these segments, the overall increase was significant (25±10% of control, 
p<0.001)(Fig 3.3D, left bar).   
 Conversely, application of SKF 38393 to thoracic and sacral segments of the 
spinal cord produced no significant change from baseline (p<1)(Fig 3.3D, right bar).  
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Specifically, in 3 of 6 applications, the reflex amplitude was increased (5±0.5% of 
control) and in 3 of 6 applications the reflex amplitude was decreased (-9±7% of control). 
 The difference in MSR amplitude response to the application of SKF 38393 
between lumbar segments L3-L5 and IML-containing thoracic/sacral segments was 
significant (p<0.04). 
 See Table 3.1 for a summary of the DA-mediated effects on the MSR between 
segments with and without autonomic innervation. 
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Table 3.1 Summary of Differential MSR DA Responses 
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Effect of Dopaminergics on the LLR 
 In order to study the effects of DA and DA-receptor ligands on the LLR amplitude 
between segments of the spinal cord with and without the IML, we bath-applied the 
following compounds: 1 µM DA (considered a low concentration), 1 µM quinpirole (D2 
agonist), 10 µM raclopride in combination with 1 µM DA (D2 antagonist), and 10 µM 
SKF 38393 (D1 agonist).  See Fig 3.4. 
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DA and DA Receptor Agonist and Antagonist Modulation of LLR in  
Lumbar and IML-containing Segments 
 
 
Figure 3.4 
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Figure 3.4 Legend 
A.  Application of 1 µM DA to the bath generally led no significant change from baseline 
in the lumbar segments (L3-L5) of the spinal cord (left bar, n=8).  Application of 1 µM 
DA to the bath generally led no significant change in LLR from baseline in the segments 
of the spinal cord containing IML (right bar, n=14).  The difference in MSR amplitude 
response to 1 µM DA application between the lumbar segments of the spinal cord with 
no IML compared to all segments with IML was not significant. 
B.  In lumbar segments (L3-L5) of WT mice, with the application of 1 µM quinpirole, the 
reflex amplitude was significantly reduced from baseline (left bar, n=7).  In IML-
containing segments (T1-L2, L6-S1), however, 4 out of 5 applications increased in reflex 
amplitude (right bar, n=5).  The difference in MSR amplitude response to 1 µM 
quinpirole application between the lumbar segments (L3-L5) of the spinal cord with no 
IML compared to all segments with IML was not significant. 
C.  The application of 10 µM raclopride and 1 µM DA to lumbar segments (L3-L5) of WT 
mice led to no overall change in reflex amplitude from (left bar, n=8).  IML-containing 
segments (T1-L2, L6-S1) had no overall change in reflex amplitude in response to this 
drug combination (right bar, n=5).  The difference in LLR amplitude response to 10 µM 
raclopride and 1 µM DA application between the lumbar segments of the spinal cord 
(L3-L5) and segments with IML was not significant. 
D.  The application of 10 µM SKF 38393 to lumbar segments (L3-L5) significantly 
increased the reflex amplitude from baseline in the lumbar segments (left bar, n=10).  
Conversely, the application of 10 µM SKF 38393 to thoracic and sacral segments of the 
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spinal cord produced no significant change from baseline (right bar, n=6). The 
difference in LLR amplitude response to 10 µM SKF 38393 applications between the 
lumbar segments of the spinal cord compared to thoracic/sacral segments of the cord 
approached significance. 
 
* = different than baseline 
# = different than lumbar 
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Effect of low dopamine  
 Application of 1 µM DA to the bath generally had no significant effect on the 
modulation of LLR amplitudes in the lumbar segments (L3-L5) of the spinal cord (Fig 
3.4A, left bar).  Specifically, in 5 of 8 applications, DA depressed the reflex amplitude (-
23±11% of control) and in 3 of 8 applications it increased the reflex amplitude (56±22% 
of control), leading to no overall to a change from baseline (6 ±17% of control, p<0.44). 
 Similarly, 1 µM DA had no significant effect on LLR amplitudes in the segments 
of the spinal cord containing IML (T1-L2, L6-S1).  Specifically, in 9 of 14 applications, 
the LLR amplitude was increased from baseline (40±22% of control).  In 5 of 14 
applications, the LLR showed a decrease from baseline (-15±6% of control)(Fig 3.4A, 
right bar), leading to a change in overall slight increase in LLR amplitudes (to 20±16% 
of control (p<0.21).   
 Thus, unlike the MSR, we did not find a significant difference in LLR amplitude 
response to 1µM DA application between the lumbar segments L3-L5 and IML-
containing segments (p<0.43). 
 
Effect of the D2 receptor agonist quinpirole  
 In lumbar segments L3-L5, application of 1 µM quinpirole significantly decreased 
the reflex amplitudes in 6 of 7 experiments by 25±4% of control (Fig 3.4B, left bar), and 
increased it in 1 experiment. Overall, the applications of 1 µM quinpirole lead to a 
significant decrease in LLR amplitudes in L3-L5 lumbar segments (-16±9% of control, 
p<0.02). 
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 In IML-containing segments however, the effects of the D2-receptor agonist were 
mixed. Quinpirole increased the LLR amplitude in 4 of 5 applications (109±44% of 
control) and decreased it in 1 experiment, thus yielding to an overall increase to 
76±47% of control (p<0.15)(Fig 3.4B, right bar).   
 While the quinpirole-induced decrease in LLR amplitude in L3-L5 segments was 
significant, the difference in LLR amplitude response between the lumbar segments and 
non-IML-containing segments was not significant (p<0.11). 
 
Effect of the D2 receptor antagonist raclopride  
 In contrast to the MSR findings, application of raclopride and DA to L3-L5 
segments had no effect on LLR amplitudes, with 3 of 8 applications showing a decrease 
from baseline (-8±5% of control) and 5 of 8 applications showing an increase in reflex 
amplitude from baseline (94±36% of control).  The overall change from baseline was 
56±28% of control, p<0.36. (Fig 3.4C, left bar)   
 Similarly, the raclopride/DA mix did not significantly alter LLR amplitudes in the 
IML-containing segments (overall: 20±11% of control, p<0.11, Fig 3.4C right bar). In one 
experiment, we observed a slight decrease in reflex amplitude from baseline (-14±4% of 
control) and in 3 applications we found trend towards an increase in reflex amplitude 
(28±9% of control).   
 Consequently, we did not observe any significant difference between L3-L5 and 
IML-containing spinal segments (p<0.12). 
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Effect of the D1 receptor agonist SKF 38393  
 Similar to the effects observed on the modulation of the MSR amplitude, 
application of SKF 38393 to the segments L3-L5 overall significantly increased the 
reflex amplitude from baseline (48±25% of control, p<0.02)(Fig. 3.4D, left bar). In 8 of 
10 applications we observed a strong increase (63±29% of control), and in 2 of 10 
applications, a slight decrease in LLR amplitude (-14±8% of control). 
 Conversely, application of the D1-receptor agonist to thoracic and sacral 
segments produced no significant change from baseline (p<0.07)(Fig. 3.4D, right bar).  
Specifically, in 5 of 6 applications, the reflex amplitude was increased (127±7% of 
control) and in 1 of 6 applications the reflex amplitude was decreased  (-77±4% of 
control). 
 Overall, the LLR responses to SKF 38393 in L3-L5 and IML-containing segments 
showed a strong differential trend and approached significance (p<0.056). 
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Effect of Other Monoamines on the Spinal Reflex 
 To test if the differential effects of DA modulation on IML-containing spinal 
segments and lumbar segments (L3-L5) were specific to DA or a result of general 
monoamine modulation, we tested other monoamines in the same segments.  Serotonin 
(5-HT) and noradrenaline (NA) have well-characterized responses in the lumbar 
segments (L3-L5), but similarly to DA, have not been studied in detail with respect to 
reflex modulation in the IML-containing segments.   
 
Effect of Other Monoamines on MSR 
 In addition to DA and DA-receptor ligands, we applied the other monoamines 5-
HT and NA to the in vitro spinal cord preparation to observe the change in amplitude of 
the MSR in segments of the spinal cord with and without the IML.  See Fig 3.5. 
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5-HT and NA Modulation of MSR in Lumbar and IML-containing Segments 
 
Figure 3.5 
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Figure 3.5 Legend 
A.  The application of 10 µM 5-HT to the lumbar segments (L3-L5) led to an overall 
decrease from baseline in all applications (left bar, n=9).  Similarly, the application of 5-
HT to IML-containing segments produced an overall decrease from baseline in all 
applications (right bar, n=7).   
B.  The application of 10 µM NA to the lumbar segments (L3-L5) led to a slight albeit 
insignificant increase from baseline (left bar, n=11), and increased SRA in IML-
containing segments significantly (right bar, n=13). We did not observe any significant 
differences in the effects of either 5-HT or NA modulation between L3-L5 and IML-
containing segments. 
 
* = different than baseline 
# = different than lumbar 
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Effect of 5-HT  
 Application of 5-HT (10 µM) to the lumbar segments (L3-L5) led to a consistent 
and significant decrease from baseline in all 9 experiments (by -36±10% of control, 
p<0.001)(Fig 3.5A, left bar).  Similarly, the application of 5-HT to IML-containing 
segments produced an overall decrease from baseline in 7 of 7 applications (by -18±3% 
of control, p<0.001)(Fig 3.5A, right bar).  We did not find any significant difference 
between the lumbar (L3-L5) and IML-containing segments with the application of 5-HT 
(p<0.1). 
 
Effect of NA  
 In contrast to 5-HT, application of NA (10 µM) to the lumbar L3-L5 segments led 
to no overall change from baseline (6±7% of control, p<0.5)(Fig 3.5B, left bar).  
Specifically, in 6 of 10 applications, MSR amplitudes increased from baseline (15±10% 
of control), while in 4 of 10 applications, MSR amplitudes were slightly decreased (-
6±4% of control). In contrast, application of NA to IML-containing segments led to an 
overall increase over the control (by 24±9%, p<0.02)(Fig 3.5B, right bar).  Specifically, in 
10 of 13 applications, the reflex amplitude was increased from baseline (33±4% of 
control).  In 3 of 13 applications, the reflex amplitude was decreased (-6±1% of control).  
Despite the significant increase in MSR amplitude there was no significant difference 
between L3-L5 and IML-containing segments with the application of NA (p<0.2). 
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Effect of Other Monoamines on the LLR 
 In addition to DA and DA-receptor ligands, we applied the other monoamines 5-
HT and NA to the in vitro spinal cord preparation to observe the change in amplitude of 
the LLR in segments of the spinal cord with and without the IML.  See Fig 3.6. 
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5-HT and NA Modulation of LLR in Lumbar and IML-containing Segments 
 
Figure 3.6 
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Figure 3.6 Legend 
A.  The application of 10 µM 5-HT to the lumbar segments (L3-L5) led to an overall 
decrease from baseline (left bar, n=4).  Similarly, the application of 5-HT to IML-
containing segments produced no overall change from baseline (right bar, n=2).  There 
was no significant difference between the lumbar (L3-L5) and IML-containing segments 
(T1-L2, L6-S1) with the application of 5-HT. 
B.  The application of 10 µM NA to the lumbar segments (L3-L5) led to no overall 
change from baseline (left bar, n=5).  The application of 10 µM NA to IML-containing 
segments (T1-L2, L6-S1) led to an overall increase from baseline in all experiments 
(right bar, n=4).  There was no significant difference between lumbar (L3-L5) and IML-
containing segments (T1-L2, L6-S1) with the application of 10 µM NA. 
 
* = different than baseline 
# = different than lumbar 
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Effect of 5-HT  
 Application of 5-HT to the L3-L5 segments led to a consistent significant 
decrease from baseline in 4 of 4 applications (-51±7% of control, p<0.03)(Fig 3.6A, left 
bar).  The application of 5-HT to IML-containing segments produced no overall change 
from baseline in 2 of 2 applications (-44±10% of control, p<0.33)(Fig 3.6A, right bar).  
Importantly, with the application of 5-HT, we did not find any significant difference 
between L3-L5 and IML-containing segments (T1-L2, L6-S1)(p<0.6). 
 
Effect of NA  
 Application of NA to L3-L5 segments led to no significant change from baseline 
(50 ±47% of control, p<0.31)(Fig 3.6B, first bar).  Specifically, in 2 of 5 applications, the 
reflex amplitude was increased from baseline (163±15% of control), while in 3 of 5 
applications, the reflex amplitude was decreased (-25±14% of control).  In IML-
containing segments, application of NA to IML-containing segments led to an overall 
increase from baseline in 4 of 4 experiments (783±321% of control, p<0.03)(Fig 3.6B, 
second bar).  There was a trend for significance between lumbar (L3-L5) and IML-
containing segments (T1-L2, L6-S1) with the application of NA (p<0.06).  Previous 
studies have noted a larger increase from baseline with the application of this 
concentration of NA and there is no opposite effect seen between lumbar (L3-L5) and 
IML-containing segments; more experiments are necessary to rule out an actual 
difference between these segments, but for the purposes of this study, we will assume 
that if there is a difference with NA, it is not of the same magnitude as what is seen with 
DA. 
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 Together, these data suggest that the switch in modulation seen between lumbar 
(L3-L5) and IML-containing segments is DA-specific and does not extend to include all 
monoamines.   
 
Effect of Dopaminergic Drugs in Combination with Gap Junction Blockers 
 We applied gap junction blockers (quinine and carbenoxolone), in combination 
with dopaminergic drugs, to the IML-containing segments of the spinal cord to identify a 
possible route of communication between somatic and autonomic motor neurons.  
These drugs, when applied with the dopaminergics, reversed the effects previously 
seen with DA and DA receptor ligands applied alone in those segments.  The 
application of the gap junction blocker alone had no effect on either the lumbar (L3-L5) 
or IML-containing segments (T1-L2, L6-S1)(data not shown).   
 The application of 10 µM quinine and 1 µM DA to IML-containing segments 
reversed the effect seen previously with 1 µM DA to that area.  Specifically, in 3 of 5 
applications, the reflex amplitude was increased relative to baseline (8±3% of control).  
In 5 of 8 applications, the reflex amplitude was decreased when compared to baseline (-
4±1% of control).  The overall effect of this drug combination in the IML segments was 
no change from baseline (0±3% of control, Fig. 3.7A).  The change from IML-containing 
segments with only 1µM DA approached significance (p<0.054). 
 The application of 10µM quinine and 1µM quinpirole (n=2) and 100µM 
carbenoxolone and 1µM quinpirole (n=1) to the IML-containing segments also reversed 
the effect seen previously with 1 µM quinpirole to that area.  In all three applications, the 
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amplitude was reduced to -45±13% of control (Fig. 3.7B).   The change from IML-
containing segments with only 1µM quinpirole was significant (p<0.001). 
 Further, a single application of 100µM carbenoxolone, 10µM raclopride, and 1µM 
DA in the IML-containing region reversed the effect seen previously with the application 
of 10 µM raclopride and 1 µM DA to that area (28% of control, Fig. 3.7C). 
 Taken together, the application of gap junction blockers quinine and 
carbenoxolone reversed the DA-mediated effect seen on the MSR in the IML-containing 
segments.  
 LLR was present with the application of dopaminergic drugs and gap junction 
blockers (and generally followed the same pattern of change in amplitude as the MSR), 
however, there were too few experiments available to present a complete analysis. 
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MSR Response to Gap Junction Blockers in Combination with DA and DA Receptor 
Agonists and Antagonists in IML-containing Segments 
 
 
Figure 3.7  
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Figure 3.7 Legend 
A.  The application of 10 µM quinine and 1 µM DA to IML-containing segments reversed 
the effect seen previously with 1 µM DA to that area.  The overall effect of this drug 
combination in the IML segments was no change from baseline (right bar, n=8).  The 
change from IML-containing segments with only 1µM DA was near significance. 
B.  The application of 10 µM quinine or 100 µM carbenoxlone with 1 µM quinpirole to 
the IML-containing segments reversed the effect seen previously with 1 µM quinpirole to 
that area.  In all three applications, the amplitude was significantly reduced from 
baseline (right bar, n=3).  This change from IML-containing segments with only 1µM 
quinpirole was significant. 
C.  One application of 100µM carbenoxolone, 10 µM raclopride, and 1 µM DA in the 
IML-containing region caused the MSR amplitude to reversed the effect seen previously 
with the application of 10 µM raclopride and 1 µM DA to that area (right bar, n=1). 
 
* = different than baseline 
# = different than lumbar  
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DISCUSSION 
 
 In this study we present the first evidence that the modulation of spinal cord 
reflex circuits by descending monoamines is associated with the presence of the 
absence of the spinal autonomic nervous system (ANS). In particular, we show that in 
the isolated spinal cord in vitro, dopaminergics modulate the monosynaptic reflex 
circuitry in a region-specific opposing manner. Application of low DA or a D2-receptor 
agonist induced depression of spinal reflexes in spinal segments void of ANS 
innervation (L3-L5) that was mirrored by a corresponding reflex facilitation in spinal 
segments containing an intermediolateral nucleus (IML). In contrast, a D1-receptor 
agonist-mediated facilitation of spinal reflexes in L3-L5 was paralleled by a decrease in 
reflex amplitude in IML-containing segments. Intriguingly, these differential modulatory 
effects were DA-specific, as the monoamines 5-HT or NA were unable to evoke similar 
region-specific neuromodulatory actions. Further, bath-application of the gap junction 
blocker quinine was able to prevent the differential DA-modulatory effects in the IML-
containing segments. Quinine not only interferes with gap junctions, but also has been 
shown to modulate K+ channels in addition to gap junctions.  This suggests that the 
region-specific DA modulation of spinal reflex could be mediated through gap junctions, 
IML-affiliated K+ channels, or both (Findlay, et al, 1985, Srinivas et al., 2001). 
 
Effect of Dopaminergics on the MSR 
Modulatory effects of DA  
 We report that a low concentration of DA (1 µM) can modulate spinal reflex in an 
opposing manner in different segments of the spinal cord.  As seen in previous studies, 
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this concentration of DA tends to have an inhibitory effect on the MSR in WT mice 
(Clemens and Hochman, 2004).  However, when the same concentration of the drug is 
applied to segments of the spinal cord containing autonomic innervation, spinal reflex is 
instead facilitated.  This is a novel finding, which has not been published to date.  In a 
2012 study, a tadpole spinal cord preparation was used to study these opposing 
modulatory effects of DA on a central pattern generator during fictive swimming.  Under 
low DA, the bursts of tail-based swimming movement was decreased, while under high 
DA, it was increased.  With the use of DA ligands, the reduction in locomotor activity 
seen with low DA is mimicked with a D2 agonist and the increase in locomotor activity 
with high DA is mimicked with the D1 agonist (Clemens et al., 2012).  Thus, the 
application of low DA (1 µM) would be expected to preferentially activate the D2-like 
receptors over the D1-like receptors, therefore causing a decrease in cellular excitability.  
This is generally what we found in the lumbar (L3-L5) segments.  However, we 
observed a facilitation of reflex strength in the segments with autonomic innervation, 
suggesting the segments containing the IML have cells that respond differently to DA 
than what has previously been reported in the lumbar segments. 
 
Modulatory effects of DA receptor agonists and antagonists  
 The application of D2 and D1-specific receptor agonists and antagonists further 
revealed the differential response between lumbar (L3-L5) and IML-containing (T1-L2, 
L6-S1).   
 The D2 specific agonist quinpirole mimicked in the lumbar segments the MSR 
amplitude change seen with 1 µM DA.  This outcome has been seen in previous studies 
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using this technique (Clemens and Hochman, 2004, Clemens et al., 2012).  
Furthermore, the same application of this drug in the IML-containing segments 
facilitated the MSR amplitude, again similar to what was observed with the application 
of low DA in those segments.  This suggests that the low application of DA used in 
these experiments was preferentially targeting the D2-like receptors over the D1-like 
receptors.  We conclude from this data that the D2-like receptors mediate the inhibition 
of reflex strength in the lumbar (L3-L5) segments, and likewise, can also bring about the 
facilitation of reflex strength in the IML-containing segments. 
 The D2 specific antagonist raclopride was used to verify the effect seen with the 
D2 agonist; it opposed the response seen with 1 µM DA in the lumbar segments and 
mimicked the actions of 1 µM DA in the IML-containing segments.  The effect of 
raclopride in the L3-L5 segments agree with what has been reported previously 
(Clemens et al., 2012), however the effect of raclopride in the IML-containing segments 
has not previously been reported. 
 We next tested if the differential response seen between segments with and 
without the IML was exclusively mediated by the D2 receptor.  The D1 specific agonist 
SKF 38393 increased the MSR amplitude in the L3-L5 segments, however in the IML-
containing segments, the MSR amplitude was not different than baseline and the 
difference between these two regions was significant.  The effects of this drug in this 
specific preparation have not been previously reported.  From this data we conclude 
that the reversal of reflex strength seen between lumbar (L3-L5) and IML-containing 
segments can occur through both D2-like and D1-like receptors.  
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Effect of Dopaminergics on the LLR 
Modulatory effects of DA  
 After we observed the differential MSR response between segments of the spinal 
cord with and without autonomic innervation, we investigated if this effect would be 
similar in the LLR circuit as well.  Previous studies have shown that the MSR and LLR 
can be modulated differentially by DA, albeit at a different concentration than what we 
used (we used 1 µM DA, while a previous study used 1 µM-100 µM DA and the 
differential modulation of LLR was seen at only the 10 µM application)(Clemens and 
Hochman, 2004).  In our hands, 1 µM DA did not have a conclusive effect on LLR; 
possibly because we did not have enough experiments with LLR present when only DA 
was added to the bath (L3-L5: n=8; T1-L2, L6-S1: n=14) and/or because of the large 
amount of variation across experiments.  
 
Modulatory effects of DA receptor agonists and antagonists  
 As with DA, the LLR response to D2 and D1-specific receptor agonists and 
antagonists showed a similar trend to the MSR response in the case of the D2 agonist 
quinpirole in the L3-L5 and IML-containing segments.  In the case of the D2 antagonist 
raclopride, the LLR change was not significant for either the L3-L5 or the IML-containing 
segments.  The D1 agonist SKF 38393 in the L3-L5 segments did show an increase 
from baseline similar to what was seen with the MSR and the IML-containing segments 
were also similar to the MSR in that the change was not significantly different from 
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baseline.  From this data we conclude that the switch in DA modulation of spinal cord 
reflex is circuit specific to the MSR and does not apply to the LLR circuitry.  
 
Modulatory Effects of Other Monoamines on the MSR and LLR  
 In the lumbar spinal cord, neuromodulatory actions of the monoamines, 5-HT and 
NA, have been studied in detail (Lew et al., 1992, Tanaka et al., 1997, Kiehn et al., 1999, 
Garraway and Hochman, 2001, Clemens and Hochman, 2004).  However, their actions 
have not been studied in the context of modulating spinal reflex in the spinal cord 
segments that contain the IML. Past studies have indicated that 5-HT tends to depress 
spinal reflex activity in the rat neonatal spinal cord (Machacek et al., 2001).   We found 
a similar depression of reflex in the L3-L5 segments (both MSR and LLR) to what has 
been found in previous studies (Crick and Wallis, 1991, Machacek et al., 2001).  
Importantly, we did not see any difference in 5-HT modulation of spinal reflex between 
the lumbar segments of the spinal cord without IML when compared to the segments 
with IML.  This was a first indication that the region-specific differential modulation of 
spinal reflex occurs was DA-specific. 
 Early studies on the precursor to DA and NA (L-DOPA) showed a facilitation of 
reflex activity (MSR and LLR) in the L4-L5 segments in the rat spinal cord (Tanabe et al., 
1990).  This was thought to occur through spinal α1 and α2-adrenoreceptors, pointing to 
a role for NA in modulating these reflexes.  A more recent study involving the 
noradrenergic modulation of activity in the lumbar dorsolateral nucleus (located in the 
L6 segment) of the rat showed an increase in excitability of these motoneurons (Yashiro 
et al., 2010).  We observed a small increase in spinal reflex amplitudes from baseline in 
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the L3-L5 segments, and a substantial increase from baseline in the IML-containing 
segments.  However, there was no significant change between the two areas of the 
cord under NA, thus supporting the hypothesis of a DA-specific differential modulation. 
 
Modulatory Effects of Gap Junction Blockers on Spinal Reflex 
 Motoneurons are coupled to each other via gap junctions, as are sympathetic 
preganglionic neurons (SPNs)(Marina et al., 2008), however it remains unknown if such 
gap junctions also exist between motoneurons and SPNs. We therefore sought to 
explore the potential role of gap junctions in the differential DA-drive modulatory actions 
observed. Gap junctions formed by connexin36 (Cx36) are known to be specific to 
neural tissue (Hormuzdi et al., 2001, Christie et al., 2005).  Quinine is a specific blocker 
of Cx36 gap junction channels, while carbenoxolone targets Cx43, another neural gap 
junction channel (Srinivas et al., 2001, Russo et al., 2008). Both gap junction blockers, 
when applied in combination with dopaminergics, were able to reverse the effects of the 
dopaminergic drugs in the IML without the gap junction blocker.  However, both quinine 
and carbenoxolone also exert non-specific actions. For example, in addition to blocking 
gap junctions, quinine is known block G-protein coupled inwardly rectifying K+ (GIRK) 
channels in many different tissues, including pancreas, heart, nervous system, and liver 
(Lebrun et al., 1982, Cherubini et al., 1984, Jung and Brierley, 1984, Cook and Haylett, 
1985).  GIRK channels are activated by G-proteins, either through direct interaction of 
the G-protein and the ion channel, or through second messenger pathways (Brown, 
1990, Breitwieser, 1996, Dascal, 1997).  “The wide distribution of GIRK subunits in 
channels are modulated by G proteins, most via second the brain and the potential for 
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regulation of neurotransmitters suggest important physiological roles for GIRKs in the 
central nervous system” (Dascal, 1997).  DA is known to regulate the activity of the 
GIRK channel, through both D1 and D2 receptors, in neural tissue (Dascal, 1997, 
Kuzhikandathil and Oxford, 2002, Marowsky et al., 2005, Sahlholm et al., 2008).  D1 
receptors in paracapsular intercalated cells in the amygdala have been shown to inhibit 
the activity of these cells on a systemic level, while at the same time causing excitation 
of interneurons in the basolateral amygdala (Marowsky et al., 2005).  The inhibition of 
activity occurring through the D1 receptors is thought to occur not through the classical 
cAMP-mediated pathway, but instead the D1 receptor is thought to be mediating a 
decrease in excitability of the system through the opening of GIRK channels (Marowsky 
et al., 2005).  Another paper presented evidence that a D1 specific antagonist has the 
ability to close GIRK channels in the Chinese hamster ovary cell (Kuzhikandathil and 
Oxford, 2002).  Based on these observations, we believe a possible mechanism for the 
differential modulation of reflex through the actions of DA in the cells of the IML could 
involve D1 receptor-mediated opening of the GIRK channel in those cells.  The GIRK 
channel is notably present on tonically active cells (such as SPNs), and serves the role 
of regulating the excitability of these cells (Dascal, 1997, Takigawa and Alzheimer, 
2002).  Figure 3.8 illustrates the model we put forth to explain the DA-specific 
differential modulation of spinal cord reflex.  In Figure 3.8A, the circuitry of two 
segments, L2 and L4, are presented, showing only the monosynaptic reflex circuit and 
the presence of the IML and SPN on only the L2 segment.  In Figure 3.8B, these circuits 
are examined in more detail in the L2 segment, showing the presence of the D1 and D2 
receptors on the motoneuron and on the IML.  The IML has the added presence of the 
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GIRK channel, which would be either opened or closed upon activation by the D1 or D2 
receptor.  If the activation of the D1 receptor opens the GIRK channel in the IML, as it 
does in the paracapsular intercalated cells of the amygdala, the excitability of the IML 
could be decreased through the D1 receptor (Marowsky et al., 2005).  Gap junction 
connections between SPNs and motoneurons would provide a pathway for the 
excitability of the SPN to impact the excitability of the motoneuron.  Similarly, 
carbenoxolone can also have nonspecific effects on ion channels (Rekling et al., 2000, 
Rouach et al., 2003, Vessey et al., 2004), perhaps including GIRK channels.  Thus, it is 
possible that the gap junction blockers used in our experiments were acting on ion 
channels in the IML region.  A dual effect of quinine or carbenoxolone could also explain 
both the mechanism of action on the DA receptor side and the SPN to motoneuron side. 
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Potential Model for Specific Aim #1 
 
A
  
 
B
  
 
Figure 3.8  
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Figure 3.8 Legend 
 
A.  Monosynaptic circuits are shown in both the L4 segment (no presence of IML) and 
the L2 segment (IML is present).  
B.  Focusing on the L2 segment, D1-like and D2-like receptors are present on the 
motoneuron cells and the IML cells.  As shown in previous publications, the D1 receptor 
has the ability to open GIRK channels, therefore decreasing the excitability of the SPN.  
The D2 receptor could do the opposite, closing the GIRK channels and increasing the 
excitability of the SPN. In this model, the SPN sends a presynaptic projection to the 
motoneuron and gap junctions provide a pathway for the excitability of the SPN to 
impact the excitability of the motoneuron.   
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 The results of this study indicate that dopaminergic modulation of spinal reflex 
(MSR and LLR) occur in segment-specific manner.  The lumbar segments (L3-L5) of the 
spinal cord without autonomic innervation respond in an opposite manner to those 
segments that do contain either sympathetic or parasympathetic preganglionic cell 
bodies.  While there is some evidence that gap junctions play a role in the purported 
communication between these preganglionic autonomic motoneurons and somatic 
motoneurons, the mechanism of action could possibly also be dependent on an altered 
modulation of ion channels in the IML, in particular K+.  
 There is strong in vitro evidence from this study that the presence of DA can 
have an impact on the ANS; we next asked if this monoamine could impact the ANS in 
vivo as well.
 
 
 
 
	  CHAPTER 4: THE DOPAMINE D3 RECEPTOR KNOCKOUT MOUSE MODELS 
AGING-RELATED CHANGES IN AUTONOMIC FUNCTION 
 
SUMMARY 
 
 The increased prevalence of hypertension with aging is well established, as is a 
role for the dopamine D3 receptor in the general pathophysiology of hypertension. To 
determine the specific effects of D3 dysfunction on autonomic output and cardiac 
involvement in aging associated hypertension, non-invasive blood pressure, pulse 
measurements, and echocardiography were used to compare cardiac structure and 
function in differently aged wild-type (WT) animals (2 months, 1 year, 2 years) and D3 
receptor knockout mice (D3KO). In WT animals, aging-related increases in blood 
pressure and cardiac function, accompanied by bradycardia in the oldest animals were 
observed. Interestingly, 2-month-old D3KO mice displayed blood pressure and heart 
rate values that were significantly increased over their age-matched WT controls, and 
that were comparable to those of the 2-year-old WT group.  Echocardiography revealed 
aging-related changes in WT animals, but we did not find significant differences 
between age matched young WT and D3KO mice.  Histology demonstrated the 
appearance of interstitial fibrosis in the young D3KO mice that was comparable to the 
age-related fibrosis seen in 2 year-old WT mice.  Our data suggest that the D3KO 
animal may serve as a model to better understand the role of the dopamine D3 receptor 
in the aging heart, and in particular its role in the pathophysiology of cardiovascular 
fibrosis.
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INTRODUCTION 
 The role of dopamine (DA) in the modulation of spinal reflex has been well 
characterized in several previous studies (Carp and Anderson, 1982, Lindvall et al., 
1983, Garraway and Hochman, 2001, Levant and McCarson, 2001, Clemens and 
Hochman, 2004, Clemens et al., 2012).  DA plays a role in shaping somatic motor 
output from the spinal cord (CPG) (Harris-Warrick et al., 1995, Lapointe et al., 2009, 
Clemens et al., 2012), but may also have an influence on neural circuits in other 
segments of the spinal cord that do not contribute to locomotion (cf. Chapter 3).  
Therefore, we wanted to know how the loss of a functional DA receptor would impact 
global autonomic motor output and cardiovascular performance at the level of the whole 
animal. 
 Measurement of both blood pressure and heart rate variability are noninvasive 
ways to assess the autonomic tone of the cardiovascular system (de Champlain et al., 
1980, Stein et al., 1994, Ino-Oka et al., 2011, Davis et al., 2012).  Blood pressure is 
ultimately determined by three factors: cardiac output, fluid volume, and peripheral 
resistance.  Neural reflexes involving both the SNS and PNS mediate the short-term 
control of blood pressure and together they exert control over all of these factors.  The 
SNS is the main neural regulator of peripheral resistance, as the autonomic innervation 
of the vasculature is primarily sympathetic.  A change in sympathetic tone will increase 
or decrease the diameter of blood vessels, subsequently regulating peripheral 
resistance.  Heart rate and stroke volume (cardiac output = HR x SV) are controlled by 
the PNS and SNS; therefore both divisions of the ANS have an impact on the cardiac 
output side of the equation.  The SNS also exerts an influence on changes in 
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hemodynamics and tubule transport in the kidney, and is the primary contributor to 
neural control of the long-term regulation of blood pressure (Boron and Boulpaep, 2002). 
 The rise in blood pressure with age is an indicator of an increase in sympathetic 
tone that occurs during the lifespan of an animal (de Champlain et al., 1980, Esler et al., 
2002, Thijssen et al., 2006, Malpas, 2010).  A role for DA in the pathophysiology of 
hypertension has been well established (Planz et al., 1976, Goldberg, 1984, Andrejak 
and Hary, 1986, Kuchel, 1990, Lundberg et al., 1990, Kuchel and Kuchel, 1991), and 
there is evidence for a role of both D1 and D3 receptors in the pathophysiology of 
hypertension (Asico et al., 1998, Felder et al., 2000, Sato et al., 2000, Zeng et al., 
2004a, Zeng et al., 2005, Yu et al., 2006, Zeng et al., 2006, Zeng et al., 2007, Banday 
and Lokhandwala, 2008, Zeng et al., 2008, Yu et al., 2009, Tayebati et al., 2011).  As 
the highest affinity DA receptor is the D3 type (Clemens et al., 2006, Pivonello et al., 
2007), we wanted to assess its contribution to the emergence of hypertension.  The D3 
receptor is expressed in the heart (Gomez Mde et al., 2002), and several mechanisms 
have been reported by which a failure of the D3 receptor system in the periphery might 
account for an increase in blood pressure (Asico et al., 1998, Muhlbauer et al., 2000, 
Jose et al., 2002), including an interaction with the D1 receptor subtype (Jose et al., 
1999, Zeng et al., 2004a, Zeng et al., 2004b), with angiotensin II (Zeng et al., 2003), 
endothelin binding receptors (Yu et al., 2009), and the G protein-coupled receptor 
kinase 4 in the kidney (Kim et al., 2005, Villar et al., 2009, Jose et al., 2010).  Since 
increases in autonomic output and corresponding cardiac function observed with age 
are well established, and since D3 receptor knockout animals have been found to 
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express hypertension (Asico et al., 1998), we addressed the question if a dysfunction of 
the D3 receptor system can mimic aging-related changes in the murine animal model.  
 Using non-invasive blood pressure measurements, functional echocardiography, 
and histology on the hearts of differently-aged WT animals (2-3 months, 1 year, 2 years), 
we found an aging-related increase in blood pressure and cardiac dysfunction, which 
was accompanied by bradycardia in the oldest animals. Intriguingly, the 2-3 month old 
D3KO cohort displayed blood pressure and heart rate values that were significantly 
increased over their age-matched WT controls but similar to those of the 2 year-old WT 
group. While the echocardiography did reveal morphological differences between young 
and old WT, we did not observe any such differences between the young and age-
matched WT and D3KOs. However, functional data derived from the echocardiography 
indicate that fractional shortening and ejection fraction showed an aging-related decline 
in WT, and that these parameters were similar between old WT and young D3KO. 
 Histological analyses revealed an aging-related increase in interstitial fibrosis in 
the myocardium of WT animals, with fibrosis in the 2 year-old WT animal group 
equivalent to that observed in the 2 month-old D3KO animals.  
 Taken together, our data suggest that aging-related changes in hypertension and 
cardiac fibrosis of WT animals are partially mimicked in young D3KOs. Thus, D3KOs 
may provide a model to understand the role of the dopamine D3 receptor in aging heart 
function, and in particular its role in the associated fibrotic remodeling.  
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RESULTS 
Weight of Animals 
 One of the common reasons for a chronic change in blood pressure is related to 
a change of the fluid volume in the body, which is associated to the overall body weight. 
Table 4.1 lists body weights of the four animal cohorts. We observed significant 
increases in body weight between 2-month-old WTs (26.83±0.47g) and 1-year-old WTs 
(42.49±2.2 g), between 2-month-old WT and 2 years-old WTs (35.15±1.13g), and 
between 1-year-old WTs and D3KOs (28.96±0.63g, p<0.001). However, we did not 
detect any differences between young WTs and young D3KOs, suggesting that any 
potential differences in blood pressure or heart rate did not arise from differences in 
body mass or fluid volume between the age-matched animals.  
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Animal Weights 
 
  
2 mo WT 
 
 
1 yr WT 
 
2 yrs WT 
 
2 mo D3KO 
Body weight (g) 26.83 ± 1.48  
42.49 ± 6.98 
♯ 
35.15 ± 3.57  
§ 
28.98 ± 1.99 
♪ 
 
Table 4.1 
 
Average values ± S.E. 
♯ = significant difference between 2 mo WT and 1 yr WT 
§ = significant difference between 2 mo WT and 2 yrs WT 
♪ = significant difference between 1 yr WT and 2 mo D3KO 
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Autonomic Evaluation of WT and D3KO Animals  
 Non-invasive blood pressure and heart rate recordings were obtained from a total 
of 30 WT of different ages and 6 young D3KO animals. WT animals were grouped in 
cohorts of young (2-3 months, n=10), 1-year-old animals (n=12), and 2-year-old animals 
(n=8). On average, animals in each group were subjected to 5.7±0.15 sessions, with the 
first 3 sessions used to acclimate the animals and the last 3 sessions used for data 
analysis. On average, 7.6±0.13 readings/parameter/session were made, and a total of 
5305 systolic and diastolic blood pressure and pulse measurements were used for data 
analysis. 
 In WT animals, aging was accompanied by a gradual increase in systolic and 
diastolic blood pressures (Fig. 4.1). Systolic values were similar between 2-month- and 
1-year-old animals (94.17±1.94 mmHg and 96.57±1.95 mmHg, respectively) but 
significantly increased by year 2 to 143.76±3.57 mmHg (p<0.001, Fig. 4.1A). In contrast, 
diastolic values showed a continuous and significant rise from 42.09±0.65 mmHg at 2 
months over 56.59±1.67 at 1 year, to 83.97±3.3 at 2 years of age (p<0.001, Fig. 4.1B). 
Interestingly, systolic blood pressure in 2 month-old D3KOs was similar to the 2-year-
old WT cohort (141.85±2.72 mmHg), but was significantly higher than both the 2-month- 
and 1-year-old WTs (Fig. 4.1A). Similarly, diastolic values of the young D3KOs 
(69.71±1.1 mmHg) were significantly higher than the 2-month- and 1-year-old WTs (Fig. 
4.1B, p<0.001).   
 The increase in blood pressure readings in the aging WT mice was accompanied 
by a significant decrease in heart rate with age from 714.88±6.96 beats-per-minute 
(bpm) at 2 months and 735.59±8.7 bpm at 1 year to 660.85±9.3 bpm (Fig. 4.1C, 
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p<0.001).  The bradycardia in the 2-year-old WT was again mimicked in the young 
D3KOs (632±15.32 bpm, Fig. 4.1C). To assess the oxygen requirements and work load 
of the hearts, the rate pressure product (RPP) was calculated as a product of measured 
systolic blood pressure x heart rate (Fig. 4.1D). The RPP in WT rose by 41% from 
67302±1430 at 2 months and 70936±1151 at 1 year, to 94974±2530 in the 2-year-old 
animals (p<0.001), and was increased by 33% in the 2-months-old D3KOs over their 
age-matched WT controls (89565±2176, n.s. from 2-year-old WT) (p<0.001, Fig. 4.1D). 
Together, these data provide evidence that aging-related changes observed in WT can 
already be found in young D3KOs. 
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Blood Pressure, Heart Rate, and Rate-Pressure Product of  
Awake WT and D3KO Animals 
 
 
Figure 4.1 
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Figure 4.1 Legend 
 
Horizontal lines indicate significant differences between groups. 
A. Systolic blood pressure is stable in WT from 2 months to 1 year of age (94.17 +/- 
1.94 mmHg and 96.57 +/- 1.95 mmHg, respectively), but significantly increases from 
year 1 to year 2 (96.57 +/- 1.95 mmHg to 143.76 +/- 3.57 mmHg, respectively) (p<0.001, 
ANOVA).  Systolic blood pressure in 2 month-old D3KOs was similar to the 2 year-old 
WT cohort (141.85 +/- 2.72 mmHg), and was significantly higher than both the 2 month- 
and 1 year-old WTs (Fig. 4.1A). 
B. Diastolic blood pressure increases gradually with age in WT and reaches its peak at 
2 years of age (42.09 +/- 0.65 mmHg at 2 months over 56.59 +/- 1.67 at 1 year, to 83.97 
+/- 3.3 at 2 years of age, p<0.001, Fig. 1B).  Young D3KO show levels that are not as 
high as 2 years old WT, but significantly higher than 2 month- or 1 year-old WTs (69.71 
+/- 1.1 mmHg, p<0.001, ANOVA, Fig. 4.1B).  
C.  Heart rate reaches a peak in 1-year-old WT and drops significantly in 2 year-old WT 
(714.88 +/- 6.96 beats-per-minute (bpm) at 2 months and 735.59 +/- 8.7 bpm at 1 year 
to 660.85 +/- 9.3 bpm, Fig. 1C, p<0.001).  Values are similar between 2 year-old WT 
and 2 month-old D3KO (632 +/-15.32 bpm, Fig. 4.1C).   
D. The RPP in WT rose by 41% from 67302 +/- 1430 at 2 months and 70936 +/-1151 at 
1 year, to 94974 +/-2530 in the 2 year-old animals (p<0.001), and was increased by 
33 % in the 2 months-old D3KOs over their age-matched WT controls (89565 +/-2176, 
n.s. from 2 year-old WT) (p < 0.001, Fig. 4.1D). 
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Echocardiography 
  To determine if aging-related changes in blood pressure and heart rate in WT 
and D3KOs were related to cardiac function, we performed ultrasound echocardiograms 
in anesthetized animals. Echograms were obtained and analyzed from 2-month-old 
WTs (n=9), 1-year-old WTs (n=7), 2-year-old WTs (n=6), and 2-month-old D3KOs (n=5), 
and data are reported in Table 4.2. Overall, ten morphological and functional 
parameters were measured or calculated and compared between all groups. Comparing 
1-year-old WT with 2-month-old WT mice, we found significant increases in systolic 
diameter (p<0.024), lateral ventricle (LV) mass (p<0.003), systolic volume (p<0.019), 
diastolic volume (p<0.028), and cardiac output (p<0.001). At 2 years of age, WT 
animals exhibited further increases in systolic diameter (p<0.024) and systolic volume 
(p<0.019), but significantly reduced ejection fraction (p<0.033) and fractional shortening 
(p<0.017) when compared to the young group. Interestingly, when adjusted for body 
weight, LV mass was no longer significantly different across all WT age groups. 
 In contrast, when comparing the 2-year-old WTs with the 2-month-old D3KOs, 
we found significant reductions in systolic and diastolic diameters (p<0.024 and p<0.027, 
respectively), total (p<0.003) and body weight-corrected (p<0.006) LV mass, diastolic 
volume, stroke volume, and cardiac output (p<0.028, p<0.045, and p<0.001, 
respectively). LV mass, LV mass corrected for bodyweight, systolic and diastolic volume, 
stroke volume, and cardiac output were also significantly different between 2-month-old 
D3KOs and 1-year-old WTs. Importantly, both ejection fraction and fractional shortening 
were significantly decreased in D3KO over their age-matched WT controls (p<0.012 and 
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p<0.01, respectively), suggesting that cardiac dynamic function is compromised in 
young D3KOs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  85	  
Echocardiogram Traces from 2-month-old, 1-year-old, and  
2-year-old WT and 2-month-old D3KO Animals 
 
 
 
Figure 4.2 
  
2 month WT 
1 year WT 
2 year WT 
2 month D3KO 
250 ms 
5 mm 
AW 
PW 
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Figure 4.3 Legend 
The LV area tool (blue line) was used to trace the anterior and posterior walls of the left 
ventricle.  An aging-related increase in anatomical parameters (systolic and diastolic 
diameters) was revealed after analysis of the echocardiograms, but no difference 
between age-matched WT and D3KO. In contrast, fractional shortening and ejection 
fraction (parameters of cardiac function) decrease in WT with age, and are in young 
D3KO similar to those of the 2-year old WT. 
Green: systolic diameter 
Red: diastolic diameter 
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Echocardiogram Analysis 
 
    
2 mo WT 
  
  
1 yr WT 
  
2 yrs WT 
  
2 mo D3KO 
Systolic 
diameter 
(mm) 
2.22 ± 0.56 
  
2.73 ± 0.45 
♯ 
2.83 ± 0.26 
§ 
2.21 ± 0.25 
♪ 
Diastolic 
diameter 
(mm) 
3.51 ± 0.52 
  
4.05 ± 0.57 
  
3.9 ± 0.38 
  
3.26 ± 0.25 
♪ 
Ejection 
fraction (%) 
68 ± 3.2 
  
61.65 ± 1.6 
  
53.18 ± 3.9 
§ 
55 ± 2.9 
€ 
Fractional 
shortening 
(%) 
37.76 ± 2.5 
  
32.84 ± 1 
  
27.39 ± 2.6 
§ 
28 ± 2.9 
€ 
LV mass 
(mg) 
94.66 ± 
13.88 
  
138.52 ± 
32.56 
♯ 
133.64 ± 
17.38 
§ 
72.29 ± 
10.67 
♪, ✚ 
LV mass / 
body 
weight (%) 
0.35 ± 0.05 
  
0.33 ± 0.08 
  
0.38 ± 0.05 
  
0.25 ± 0.04 
€, ♪, ✚ 
Systolic 
volume (µl) 
18.6 ± 10.57 
  
29.21 ± 
10.71 
♯ 
31.11 ± 6.57 
§ 
18.05 ± 3.05 
✚ 
Diastolic 
volume (µl) 
52.99 ± 18.5 
  
74.28 ± 
22.62 
♯ 
67.17 ± 
15.85 
  
43.81 ± 8.31 
♪, ✚ 
Stroke 
volume (µl) 
34.39 ± 8.2 
  
45.07 ± 
12.41 
  
36.06 ± 
14.31 
  
25.76 ± 7.96 
♪ 
Cardiac 
output 
(ml/min) 
12.55 ± 2.8 
  
21.14 ± 5.52 
♯ 
14.59 ± 5.23 
  
9.32 ± 3.14 
♪, ✚ 
 
Table 4.2: 
Average values ± S.E.  
♯ = significant difference between 2 mo WT and 1 yr WT 
§ = significant difference between 2 mo WT and 2 yrs WT 
€ = significant difference between 2 mo WT and 2 mo D3KO 
♪ = significant difference between 1 yr WT and 2 mo D3KO 
✚ = significant difference between 2 yrs WT and 2 mo D3KO 
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Morphometric Analyses 
 
  We next assessed the morphometric features of the hearts, and measured LV, 
LV chamber area, and myocyte cross-sectional areas (MCSAs) of endo- and 
epicardium in WT and D3KO animals (Table 4.3).  We found an aging-related trend in 
WT animals for an increase in LV and LV chamber area, a significant increase in both 
myocyte cross-sectional area (MCSA) endo- and epicardium area in 1-year-old animals 
(p<0.001), and a concomitant bi-phasic change in MCSA endocardium area with a peak 
in the 1-year-old animals (p<0.001). In contrast, MCSA areas were not significantly 
different between age-matched WT and D3KOs. Thus the increase in blood pressure 
and the bradycardia observed in young D3KOs appears to not stem from changes in LV 
or MCSA areas. 
 
Fibrosis Measurements 
 Cardiac fibrosis is a hallmark of heart disease and hypertension (Biernacka and 
Frangogiannis, 2011). We therefore assessed with histological approaches the levels, 
expression pattern, and qualitative characteristics of fibrosis-related collagen in the 
heart (Fig. 4.3). Fig. 4.3A shows images from the myocardium of the left ventricle of 
each of the different age groups of WT and D3KO.  There is an increase in collagen 
staining (represented by red staining) in the group of aging WT mice from 2 months to 2 
years of age and the amount of collagen in the 2-month-old D3KO is more similar to the 
2-year-old WT.  After normalization to the 2 months-old WT, collagen expression in the 
myocardium increased in the 2 year-old cohorts by 24.8 +/- 6.1 %, and by 34.8 +/- 8.5% 
in the 2 months-old D3KOs (ANOVA, p=0.002)(Fig. 4.3B). This suggests that interstitial 
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fibrosis might play a critical role in the emergence of hypertension and bradycardia in 
the young D3KOs. 
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Morphometric Analysis 
 
  
2 mo WT 
 
 
1 yr WT 
 
2 yrs WT 
 
2 mo D3KO 
LV area (mm2) 15.79 ± 1.62  
20.38 ± 0.87 
 
20.2 ± 1.3 
 
15.02 ± 0.76 
♪, ✚  
LV chamber area (mm2) 2.11 ± 0.05  
2.24 ± 0.22 
 
2.58 ± 0.21 
 
1.51 ± 0.09 
✚ 
MCSA epicardium (mm2) 230.2 ± 13.58  
323.96 ±16.54 
♯ 
267.8 ±12.67 
 
230.93 ±13.52 
♪ 
MCSA endocardium 
(mm2) 
284.3 ± 13.98 
 
340.93 ± 12.57 
♯ 
254.72 ± 9.66 
¶ 
265.37 ± 8.26 
♪ 
 
Table 4.3: 
 
 
Average values ± S.E. 
♯ = significant difference between 2 mo WT and 1 yr WT 
§ = significant difference between 2 mo WT and 2 yrs WT 
♪ = significant difference between 1 yr WT and 2 mo D3KO 
¶ = significant difference between 1 yr WT and 2 yrs WT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  91	  
 
Interstitial Fibrosis in WT (2 months to 2 years) and Young (2 months) D3KO Animals 
 
 
Figure 4.3 
  
A
B
	  92	  
Figure 4.3 Legend 
A. Representative images of the myocardium of the left ventricle of 2 month-, 1 year- 
and 2-year-old WT, and 2 month-old D3KO mice. Images show an increased amount 
and thickness of fibrillar collagen in WT with age, and the levels of collagen in 2 year-old 
WT are comparable to the levels in the young D3KOs.  
B. A quantification of the fibrosis reveals a significant increase in fibrosis staining in 
young D3KOs over the age-matched WT control, even surpassing the fibrosis levels of 
the 2-year-old cohort. 
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DISCUSSION 
 
 We present evidence that aging is associated with an increase in autonomic 
function and interstitial fibrosis, and that the dysfunction of the dopamine D3 receptor 
can be associated with the emergence of aging-related changes in cardiac function and 
cytoarchitecture in a young D3KO animal.  Hypertension is defined as an abnormal rise 
in blood pressure, which, regardless of origin, results in either an increase in systemic 
vascular resistance or an increase in cardiac output, or both.  Thus, our data are 
consistent with the idea that D3KOs may be a new animal model to understand the role 
of the dopamine D3 receptor in aging heart function, and in particular its role in cardiac 
remodeling associated with hypertension. The rise in blood pressure during the aging 
process in humans is common and has been well-established in the literature for many 
years (Amery et al., 1978).  This seems to translate well with our group of aging WT 
mice, which showed an overall steady increase in blood pressure with age.  Specifically, 
the systolic measurement stayed level from 2 months to 1 year, but then was 
significantly increased from 1 year to 2 years, while the diastolic measurement 
increased significantly over each time point.  In our aging WT mice, we are likely seeing 
the normal progression of hypertension during the aging process from an early stage 
(borderline) to a later stage of the fully developed disease with no clear, identifiable 
cause (primary/essential)(Julius, 1988).  The literature on the why borderline 
hypertension develops and how it shifts from early to late stage is confusing and full of 
differing opinions about exactly which system(s) is/are responsible.  Among others, 
defects are cited in the renal and renin/angiotensin system (Loney et al., 2002, Failor 
and Capell, 2003, Hartman et al., 2003, Freel and Connell, 2004), the SNS (Julius et al., 
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1971, Julius, 1988, DeQuattro and Feng, 2002), and others think there are 
abnormalities during cardiovascular development which lead to the development of 
primary hypertension (Safar and Boudier, 2005).  In cases of primary hypertension, 
there is evidence that during the early stages of the disease there is first an increase in 
cardiac output, which subsequently leads to an increased vascular resistance (Julius et 
al., 1971, Julius, 1988, Palatini and Julius, 2009).  In long-term hypertensive patients, 
the blood volume returns to normal levels, but the vascular resistance remains (Conway, 
1963, Harburg et al., 1964, Sivertsson, 1970, Julius, 1988).  This division between the 
stages of hypertension is important in determining the mechanism behind the rise in 
blood pressure.  During the borderline stage of hypertension, the mechanism seems to 
be primarily neurogenic in origin and a pharmacological intervention to block the 
autonomic drive tends to reduce cardiac output and reduce blood pressure (Julius et al., 
1971, Julius, 1988, Palatini and Julius, 2009).  In the established phase of hypertension, 
however, cardiac output normalizes and “patients show a high total peripheral 
resistance, their plasma norepinephrine values are not elevated, and there is good 
evidence of a structural, non-neurogenic component in the elevation of their vascular 
resistance” (Conway, 1963, Harburg et al., 1964, Sivertsson, 1970, Julius, 1988).  In 
contrast to the aging WT, our young D3KO (2-months-old) mice showed systolic blood 
pressure nearly equal to that of 2-year-old WT animals and diastolic blood pressure that 
was significantly increased over 2-month-old and 1-year-old WT, but lower than 2-year-
old WT.   
 We considered the changes in weight and cardiac function as potential 
explanations for increased blood pressure in in the young D3KO mice.  Hypertension 
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can arise from changes in three parameters: cardiac output, fluid volume, and/or 
peripheral resistance.  The weight of our WT animals increased from 2 months of age to 
1 year of age, but did not continue to increase (and may even begin to decrease) from 1 
year of age to 2 years of age.  The systolic and diastolic blood pressure, however, did 
increase from their first to second year.  This indicates that in the WT animals the blood 
volume was increasing from 2 months to 1 year, but leveled off or began to drop by 2 
years of age, while at the same time the blood pressure of the older animals still 
significantly increased during that time.  Added to the data on the weight of the mice is 
the fact that the heart rate drops at the same time point that the weight of the animals 
drops, providing evidence that the cardiac output (heart rate x stroke volume) is reduced 
with age.  Finally, the functional echocardiography confirms that the cardiac output of 
the 1-year-old WT does increase significantly from 2-months-old, but the 2-month-old is 
no different from the 2-year-old animals for this parameter.  The D3KO animals showed 
an increased blood pressure at an early age, but showed no differences in weight when 
compared to the age-matched WT, indicating blood volume was similar between the 
young D3KO and young WT.  Also, the heart rate of these animals was lower than any 
of the WT age groups and echocardiography measurements indicate a normal cardiac 
output.  By considering the change in these parameters of weight/fluid volume (young 
D3KO and young WT weights are not different), heart rate (young D3KO have even 
lower heart rate than young WT), and functional echocardiography (cardiac output is the 
same in young D3KO and young WT), the driving force behind this increase in blood 
pressure seen in young D3KO mice seems to be a change in vascular resistance over a 
change in cardiac output.  If the mechanism behind the development of early-onset 
	  96	  
hypertension in the young D3KO animals were working through a change in vascular 
resistance through a remodeling of the vasculature, this would be more similar to what 
is seen in the older WT animals and older humans during later stages of the disease.  
This indicates that the young D3KO could be a useful model of autonomic dysfunction 
with advanced aging and that the physiology and vascular structure is more similar to 
what is found in the aged animal. 
 Adding to the idea that the lack of the D3 receptor could be driving a change in 
the structure of the vasculature is data collected from the use of dopaminergic drugs in 
the treatment of CNS disorders.  Dopamine D2 receptor agonists (specifically ergot 
derivatives), such as cabergoline or pergolide, have been used in the treatment of 
Parkinson’s disease for many years.  As early as 1995, patients treated with these 
drugs have been noted to develop fibrosis in conjunction with the delivery of the drug 
(Jimenez-Jimenez et al., 1995).  More recent studies from “population studies of 
patients with Parkinson's disease compared with non-Parkinsonian controls have 
reported that pergolide and cabergoline have a similar risk of inducing fibrotic changes 
in cardiac valve leaflets. The fibrotic changes cause thickening, retraction, and stiffening 
of valves, which result in incomplete leaflet coaptation and clinically significant 
regurgitation, and have necessitated surgical valve replacement in some patients” 
(Antonini and Poewe, 2007).  Others have since provided more evidence that these D2-
specific agonists are indeed involved in producing drug-induced fibrotic lesions in the 
heart (Andersohn and Garbe, 2009, Antonini et al., 2009, Apostolakis et al., 2009, 
Bhattacharyya et al., 2009, Izgi et al., 2010, Perez-Lloret and Rascol, 2010), however 
the mechanism for this D2 receptor-driven increase in cardiac fibrosis has not yet been 
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fully determined.  Although the focus in all of these studies was on D2-specific receptor 
agonists, it is interesting to reiterate that we have shown evidence that the young D3KO 
from our study shows an increased amount and thickness of fibrillar collagen in WT with 
age, and the levels of collagen in 2 year-old WT are comparable to the levels in the 
young D3KO.    
 Layered on top of the dysfunction of the cardiovascular system involving either 
fluid balance, peripheral resistance, or both, is the fact that ultimately both of these 
hemodynamic factors can be disturbed by an increase in sympathetic activity (Lund-
Johansen, 1994, Grassi, 2010).  The D3KO animal lacks a key inhibitory dopamine 
receptor, which is found throughout the spinal cord, including the sites of autonomic 
control (i.e. IML) that are involved in the regulation of blood pressure.  In the aging WT 
mouse, we can see a normal progression in the development of blood pressure:  
increase in weight (fluid volume), increase in cardiac output, and increase in blood 
pressure from 2 months of age to 1 year of age.  From the first to second year, however, 
the cardiac output and weight drops back to what was seen in the 2-month-old animal, 
but the blood pressure remains high.  This has been previously noted as the switch from 
a dysfunction in cardiac output to a dysfunction in vascular resistance from early stage 
hypertension (neurogenic in origin) to late stage hypertension (non-neurogenic in origin).  
However, in our D3KO animals, we see the components of a dysfunction in vascular 
resistance when compared to the 2-month-old WT animals, without the changes in 
cardiac output (i.e. they are at the late-stage of hypertension).  We cannot, however, 
rule out a neurogenic role for the D3KO animals in the development of high blood 
pressure (even if they are physiologically at the late stage) because of the fact the 
	  98	  
spinal cord of these animals lack the D3 receptor and therefore could also have a 
partially unchecked SNS drive from that component of blood pressure regulation in 
addition to the development of fibrosis. 
 We have shown an aging related increase in blood pressure in WT mice from 2 
months to 2 years of age.  The blood pressure measurements of 2–month-old D3KO 
animals, however, were most similar to the oldest WT animals (2-years-old).  We 
believe the young D3KO animals provide a new model of aging, which exhibit not only a 
similar increase in blood pressure, but similar changes to the vasculature present in 
older WT animals.
 
   
	  CHAPTER 5: CONCLUSION 
 The overall hypothesis of this study is that DA plays a role in regulating the 
autonomic nervous system with both central and peripheral effects. We can see 
evidence of this from both the perspective of the underlying spinal cord circuitry and 
from the in vivo physiological changes in global autonomic output. 
 In the first aim, we asked if DA modulation of spinal reflex would be similar in 
direction and magnitude in all segments.  Almost all previous studies on DA-mediated 
effects on spinal cord function have focused exclusively on the lumbar segments and 
the role DA may play in the recruitment of the central pattern generator (CPG) for 
locomotion (Cazalets et al., 1995, Han et al., 2007).  In addition to its role in modulating 
CPG activity, DA has also been shown to directly modulate spinal reflex in the lumbar 
segments of the spinal cord (L2-L5)(Clemens and Hochman, 2004).  In our study, we 
were interested DA modulation of reflex in segments of the spinal cord outside the 
lumbar region involved in locomotion, specifically, those segments that contain 
autonomic innervation.  In vitro data from mouse spinal cord show that areas containing 
autonomic innervation (SNS and PNS) respond differentially to DA and DA receptor 
agonists and antagonists than segments without the ANS.  Furthermore, this result 
seems to be DA-specific, as noradrenaline and serotonin had similar effects in both the 
lumbar and ANS-containing segments.  We conclude that DA mediates in vitro 
autonomic and somatic circuits in the spinal cord differently and this effect is circuit 
specific for MSR.  We have also shown that a gap junction blocker can reverse the DA 
effect, pointing also to a role for either gap junctions or ion channels in what we have 
observed.  Therefore we conclude that the switch in modulation between segments in 
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the spinal cord with and without autonomic innervation could be mediated by GIRK 
channel modulation by DA in the IML and this channel activity is regulated only by DA 
and not by other monoamines.  In this scenario, GIRK channels are present on the 
tonically active cell bodies of the IML, but are not present on motoneurons.  The ability 
of DA to regulate the opening and closing of the GIRK channel would ultimately regulate 
the activity of the SPN and gap junction connections between SPNs and motoneurons 
would provide a pathway for the excitability of the SPN to impact the excitability of the 
motoneuron. 
 After our in vitro experiments pointed to a clear role for DA in modulating the 
ANS, we asked what impact DA would have on the ANS in vivo.  We used a knockout 
mouse model lacking a key inhibitory DA receptor and compare differences in 
autonomic output in these animals to aging WT mice.  The D3KO mouse is has been 
noted as hypertensive and hyperactive, with known defects in the renal system (Asico et 
al., 1998).  Additionally, the D3 receptor has the highest affinity for DA and any 
functional problems associated with DA are likely to be linked to this receptor (Clemens 
et al., 2006, Pivonello et al., 2007).  From these studies, we can see that DA likely has a 
role in the control of autonomic function in vivo in the D3KO animal.  It is also known 
that compromised autonomic function is commonly seen in the aging population (e.g. 
hypertension, cardiac disease)(de Champlain et al., 1980, Esler et al., 2002, Thijssen et 
al., 2006, Malpas, 2010).  Therefore in the second aim of our study, we used the well-
established background for aging-associated compromise in autonomic function to test 
how the cohort of aging WT animals compared to the young D3KO animal in terms of in 
vivo blood pressure and functional echocardiography, along with histological fibrosis 
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data.  These experiments provided further evidence that DA does have an effect in the 
intact animal and is relevant to regulation of the ANS in not only the in vitro setting, but 
also in vivo.  The blood pressure and heart rate changes over time in the WT animals 
show an increase in autonomic tone associated with aging.  We have provided evidence 
in this study that animals lacking the D3 receptor show signs of advanced aging not only 
from the standpoint of an increase in blood pressure, but because these animals show 
an increase in fibrosis not typically seen until the WT animals reach 2 years of age.  We 
conclude that the D3 receptor is plays a major role in the regulation of cardiac measures 
of autonomic function and that the increase in global autonomic tone in the D3KO mice 
mimics what is seen in aging WT animals.  Whether the hypertension is caused directly 
by changes in the SNS due to the lack of the D3 receptor in the CNS or from peripheral 
effects, the autonomic changes observed in the young D3KO and old WT ultimately 
lead to high blood pressure.  This almost has to cause (if it's not being itself being cause 
by it already) autonomic dysfunction because the blood pressure in the animals is so 
high, the regulatory system (mainly SNS) is going to be trying to bring it down.  In either 
case, the autonomic nervous system is dysfunctional.  This study is important because 
it provides the first evidence that the D3KO mouse could be considered as a new model 
of advanced aging. 
 Future studies to address the unanswered questions that remain include: 
intracellular/patch clamp recording for cell-specific experiments, as opposed to our 
current method, which is recording from a population of cells.  We would expect that if 
gap junctions exist between motoneurons and SPNs, dye-coupling experiments would 
show movement of dye between these cells.  Another way to help define the role of gap 
	  102	  
junctions in a possible communication between motoneurons and SPNs would be to 
use a gap junction blocker during an intracellular recording.  In this type of experiment, 
we would be able to visualize the response of a single motoneuron when the gap 
junction connection from the motoneuron to the SPN is blocked.  If in the presence of 
the gap junction blocker, the motoneuron responds similarly to what has been seen in 
lumbar segments of the spinal cord without autonomic innervation, we would have 
further evidence that the SPN is influencing the excitability of the motoneuron through 
gap junctions.  Also within the in vitro setting, using either the suction electrode or 
intracellular approach, use of more specific ion channel blockers would more clearly 
define a mechanism for the differential DA-mediated MSR effect seen between 
segments of the spinal cord with and without autonomic innervation.  We could use K+ 
channel blockers specific for the GIRK channel to remove the influence of that single 
channel on the activity of the IML and record the subsequent response of both the SPN 
and the motoneuron.  Additionally, studies to determine the mechanism of a D3-
mediated increase in fibrillar collagen in the D3KO animal, such as western blots to 
analyze the levels of different types of collagen that are found in WT and D3KO animals.  
Levels of matrix metalloproteinases (MMPs), which are responsible for the breakdown 
of collagen, could be used to determine if they could provide a mechanism for the 
accumulation of collagen in the D3KO animals.  If the levels or activity of MMPs in the 
young D3KO resemble what is seen in the older WT, this could give us further evidence 
that an increase in collagen and subsequent increase in stiffening of the tissue of the 
heart or vasculature could be the key factor in early-onset hypertension seen in the 
young D3KO animals. 
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